{"recordsFiltered":50813,"recordsTotal":50813,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=-sponsor__name&start=36300","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&ordering=-sponsor__name&start=35700","results":[{"registry_id":"NCT07772089","publication_url":"https://clinicaltrials.gov/study/NCT07772089","title":"A Randomized, Double-Blind, Placebo-Controlled, Within-Subject Crossover Trial of a Single 4 mg Dose of Nicotine Polacrilex Gum on Psychoacoustic Tinnitus Loudness and Selective Attention in Non-Smoking Adults With Chronic Subjective Tinnitus","has_exemption":false,"start_date":"2026-03-25","completion_date":"2026-08-03","has_results":false,"results_due":false,"sponsor_name":"San Diego State University","sponsor_slug":"san-diego-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03587662","publication_url":"https://clinicaltrials.gov/study/NCT03587662","title":"Phase II Trial of Ixazomib Combined With Gemcitabine and Doxorubicin in Patients With Renal Medullary Carcinoma","has_exemption":false,"start_date":"2018-08-17","completion_date":"2026-08-04","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03974113","publication_url":"https://clinicaltrials.gov/study/NCT03974113","title":"ATLAS-PEDS: An Open-label, Multinational Study of Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B","has_exemption":false,"start_date":"2020-01-28","completion_date":"2026-08-04","has_results":false,"results_due":false,"sponsor_name":"Genzyme, a Sanofi Company","sponsor_slug":"genzyme-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05011084","publication_url":"https://clinicaltrials.gov/study/NCT05011084","title":"Randomized Control Trial of Combined Cryotherapy With Compression Versus Cryotherapy Alone After Orthopaedic Surgery","has_exemption":false,"start_date":"2020-11-02","completion_date":"2026-08-04","has_results":false,"results_due":false,"sponsor_name":"Walter Reed National Military Medical Center","sponsor_slug":"walter-reed-national-military-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05638581","publication_url":"https://clinicaltrials.gov/study/NCT05638581","title":"Trauma Resuscitation With Low-Titer Group O Whole Blood or Products","has_exemption":false,"start_date":"2023-07-27","completion_date":"2026-08-04","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06145412","publication_url":"https://clinicaltrials.gov/study/NCT06145412","title":"A Phase II Trial of Xevinapant in Combination With Post-Operative Cisplatin and Radiotherapy for High Risk Head and Neck Cancer","has_exemption":false,"start_date":"2023-11-16","completion_date":"2026-08-04","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05632328","publication_url":"https://clinicaltrials.gov/study/NCT05632328","title":"A Phase 2 Study of AGEN1423, an Anti-CD73-TGFβ-Trap Bifunctional Antibody, in Combination With Botensilimab, With or Without Chemotherapy in Subjects With Advanced Pancreatic Cancer.","has_exemption":false,"start_date":"2024-08-08","completion_date":"2026-08-04","has_results":false,"results_due":false,"sponsor_name":"Bruno Bockorny","sponsor_slug":"bruno-bockorny","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03800693","publication_url":"https://clinicaltrials.gov/study/NCT03800693","title":"Phase II Evaluation of the Effect of 2 Versus 6 Hour Oxaliplatin Infusions on Neuropathy and Pharmacokinetics in Patients With Gastrointestinal Cancers","has_exemption":false,"start_date":"2019-03-14","completion_date":"2026-08-05","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05681702","publication_url":"https://clinicaltrials.gov/study/NCT05681702","title":"Tailoring Bleeding Reduction Approaches in Patients Undergoing Percutaneous Coronary Interventions: Comparative Pharmacodynamic Effects of Potent P2Y12 Inhibitor Monotherapy Versus Dual Antiplatelet Therapy De-escalation","has_exemption":false,"start_date":"2023-02-15","completion_date":"2026-08-05","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06491563","publication_url":"https://clinicaltrials.gov/study/NCT06491563","title":"A Phase 2 Multicenter, Open-label Study to Investigate the Efficacy and Safety of Regimens Containing BRII-179, BRII-835, and Pegylated Interferon Alpha (PEG-IFNα) for the Treatment of Chronic Hepatitis B Virus (HBV) Infection (ENRICH)","has_exemption":false,"start_date":"2024-08-06","completion_date":"2026-08-05","has_results":false,"results_due":false,"sponsor_name":"Brii Biosciences Limited","sponsor_slug":"brii-biosciences-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06557772","publication_url":"https://clinicaltrials.gov/study/NCT06557772","title":"A Phase 2a/b, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of Subcutaneous Amlitelimab in Adult Patients With Nonresponsive Celiac Disease as an Adjunct to a Gluten-free Diet","has_exemption":false,"start_date":"2024-08-29","completion_date":"2026-08-05","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06892288","publication_url":"https://clinicaltrials.gov/study/NCT06892288","title":"A Phase 2b, Multicenter, Double-blind, Randomized, Placebo Controlled Study to Assess the Efficacy and Safety of Weekly Doses of GLM101 Administered Intravenously to Participants With PMM2-CDG (POLAR Trial)","has_exemption":false,"start_date":"2025-07-09","completion_date":"2026-08-05","has_results":false,"results_due":false,"sponsor_name":"Glycomine, Inc.","sponsor_slug":"glycomine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07046494","publication_url":"https://clinicaltrials.gov/study/NCT07046494","title":"A Phase 2, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of RAP-219 for the Acute Treatment of Manic Episodes, With or Without Mixed Features, Associated With Bipolar I Disorder","has_exemption":false,"start_date":"2025-07-25","completion_date":"2026-08-05","has_results":false,"results_due":false,"sponsor_name":"Rapport Therapeutics Inc.","sponsor_slug":"rapport-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07071038","publication_url":"https://clinicaltrials.gov/study/NCT07071038","title":"The 'SWIVEL' Study (Switch Vs Effects Relief): Effectiveness of a Medication 'Switch' vs Guideline-Directed Interventions for Relieving Side Effects of Aromatase Inhibitors Among Breast Cancer Patients","has_exemption":false,"start_date":"2025-10-17","completion_date":"2026-08-05","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06241560","publication_url":"https://clinicaltrials.gov/study/NCT06241560","title":"An Open-label, Single-group Trial to Evaluate the Effect of Pirfenidone on the Pharmacokinetics of a Single Oral Dose of BI 1015550","has_exemption":false,"start_date":"2026-03-05","completion_date":"2026-08-05","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04006522","publication_url":"https://clinicaltrials.gov/study/NCT04006522","title":"An Exploratory Study of 89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma","has_exemption":false,"start_date":"2019-10-02","completion_date":"2026-08-06","has_results":false,"results_due":false,"sponsor_name":"James Brugarolas","sponsor_slug":"james-brugarolas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05600426","publication_url":"https://clinicaltrials.gov/study/NCT05600426","title":"A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation With Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)","has_exemption":false,"start_date":"2023-01-25","completion_date":"2026-08-06","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06867094","publication_url":"https://clinicaltrials.gov/study/NCT06867094","title":"A Phase 2, Multinational, Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-ranging Study to Evaluate the Efficacy and Safety of SAR441566 in Adults With Moderate-to-severe Ulcerative Colitis","has_exemption":false,"start_date":"2025-03-28","completion_date":"2026-08-06","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06847191","publication_url":"https://clinicaltrials.gov/study/NCT06847191","title":"A Double-blind, Randomized Study to Evaluate the Efficacy and Safety of Bezisterim (NE3107) in Adults With Long COVID","has_exemption":false,"start_date":"2025-04-29","completion_date":"2026-08-06","has_results":false,"results_due":false,"sponsor_name":"BioVie Inc.","sponsor_slug":"biovie-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07109349","publication_url":"https://clinicaltrials.gov/study/NCT07109349","title":"Effect of Transcutaneous Auricular Neurostimulation on Mental Wellness and Resiliency for First Responders: A Pilot Trial","has_exemption":false,"start_date":"2025-09-10","completion_date":"2026-08-06","has_results":false,"results_due":false,"sponsor_name":"Spark Biomedical, Inc.","sponsor_slug":"spark-biomedical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04772131","publication_url":"https://clinicaltrials.gov/study/NCT04772131","title":"Prospective, Post-market Study of the Desara® One Single Incision Sling vs. Desara® Blue Sling Implanted Via the Transobturator Route for the Treatment of Women With Stress Urinary Incontinence","has_exemption":false,"start_date":"2021-11-01","completion_date":"2026-08-07","has_results":false,"results_due":false,"sponsor_name":"Caldera Medical, Inc.","sponsor_slug":"caldera-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05379868","publication_url":"https://clinicaltrials.gov/study/NCT05379868","title":"Posterior Column Spinal Osteotomies in the Treatment of Adolescent Idiopathic Scoliosis. A Randomized Clinical Trial","has_exemption":false,"start_date":"2022-06-01","completion_date":"2026-08-07","has_results":false,"results_due":false,"sponsor_name":"Turku University Hospital","sponsor_slug":"turku-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06832618","publication_url":"https://clinicaltrials.gov/study/NCT06832618","title":"A Phase 3b, Double-Blind, Multicenter, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Children and Adolescents (6 to <18 Years Old) With Moderate Atopic Dermatitis","has_exemption":false,"start_date":"2025-06-17","completion_date":"2026-08-07","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07779356","publication_url":"https://clinicaltrials.gov/study/NCT07779356","title":"Comparative Evaluation of Patient Comfort Following Intravitreal Injections Using Iheezo Versus Standard Anesthesia in a Private Retina Practice","has_exemption":false,"start_date":"2026-05-20","completion_date":"2026-08-07","has_results":false,"results_due":false,"sponsor_name":"Retina Consultants of Delmarva","sponsor_slug":"retina-consultants-of-delmarva","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03076034","publication_url":"https://clinicaltrials.gov/study/NCT03076034","title":"Utility of Cortical Bone Tissue Properties in the Assessment of Fracture Risk","has_exemption":false,"start_date":"2015-01-26","completion_date":"2026-08-08","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05756751","publication_url":"https://clinicaltrials.gov/study/NCT05756751","title":"IMpella®-Protected cArdiaC Surgery Trial in Europe: A European, Prospective, Multicenter, Post-Market Clinical Follow-Up Trial","has_exemption":false,"start_date":"2023-04-27","completion_date":"2026-08-08","has_results":false,"results_due":false,"sponsor_name":"Abiomed Inc.","sponsor_slug":"abiomed-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05564403","publication_url":"https://clinicaltrials.gov/study/NCT05564403","title":"FOLFOX in Combination With Binimetinib as 2nd Line Therapy for Patients With Advanced Biliary Tract Cancers With MAPK Pathway Alterations: A ComboMATCH Treatment Trial","has_exemption":false,"start_date":"2024-02-09","completion_date":"2026-08-08","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04436640","publication_url":"https://clinicaltrials.gov/study/NCT04436640","title":"A Multicenter, Open-Label Extension Study to Asses the Long-Term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Study Participants With Active Axial Spondyloarthritis, Ankylosing Spondylitis, and Nonradiographic Axial Spondyloarthritis","has_exemption":false,"start_date":"2020-06-16","completion_date":"2026-08-09","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06374758","publication_url":"https://clinicaltrials.gov/study/NCT06374758","title":"ACCELERATE a Multisite Prospective Hybrid (Effectiveness-implementation) Type 2 Design, Single-arm, Mixed-methods Study of a Simplified Accelerated ART Initiation Protocol for People With HIV Who Are Out of Care.","has_exemption":false,"start_date":"2024-04-29","completion_date":"2026-08-09","has_results":false,"results_due":false,"sponsor_name":"University of Missouri-Columbia","sponsor_slug":"university-of-missouri-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04626479","publication_url":"https://clinicaltrials.gov/study/NCT04626479","title":"A Phase 1b/2 Study of Immune and Targeted Combination Therapies in Participants With RCC (U03): Substudy 03A in First Line Metastatic Participants","has_exemption":false,"start_date":"2020-12-16","completion_date":"2026-08-10","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05183204","publication_url":"https://clinicaltrials.gov/study/NCT05183204","title":"A Phase 2 Trial of Paxalisib Combined With a Ketogenic Diet and Metformin for Newly Diagnosed and Recurrent Glioblastoma","has_exemption":false,"start_date":"2022-02-14","completion_date":"2026-08-10","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05211895","publication_url":"https://clinicaltrials.gov/study/NCT05211895","title":"A Phase III, Randomised, Double-blind, Placebo-controlled, Multicentre, International Study of Durvalumab Plus Domvanalimab(AB154) in Participants With Locally Advanced (Stage III), Unresectable Non-small Cell Lung Cancer Whose Disease Has Not Progressed Following Definitive Platinum-based Concurrent Chemoradiation Therapy","has_exemption":false,"start_date":"2022-02-18","completion_date":"2026-08-10","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05089370","publication_url":"https://clinicaltrials.gov/study/NCT05089370","title":"Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab as a Strategy to Enhance the Efficacy of Immune Checkpoint Blockade in Unresectable or Metastatic Mucosal Melanoma","has_exemption":false,"start_date":"2022-06-20","completion_date":"2026-08-10","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05267613","publication_url":"https://clinicaltrials.gov/study/NCT05267613","title":"A Phase III Study to Assess the Efficacy and Safety of NEXIUM for Maintenance of Healing of Erosive Esophagitis in Pediatric Patients 1 to 11 Years of Age","has_exemption":false,"start_date":"2022-07-01","completion_date":"2026-08-10","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05935826","publication_url":"https://clinicaltrials.gov/study/NCT05935826","title":"Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)","has_exemption":false,"start_date":"2024-06-18","completion_date":"2026-08-10","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06259097","publication_url":"https://clinicaltrials.gov/study/NCT06259097","title":"Misoprostol Versus Pitocin for Induction of Labor in Patients With BMI > 30: A Randomized Controlled Trial","has_exemption":false,"start_date":"2024-07-02","completion_date":"2026-08-10","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06671938","publication_url":"https://clinicaltrials.gov/study/NCT06671938","title":"A Phase 2a, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Ascending Dosing of Exidavnemab in Patients With Mild to Moderate Parkinson's Disease on Stable Symptomatic Parkinson's Disease Medication and in Patients With Multiple System Atrophy","has_exemption":false,"start_date":"2024-10-24","completion_date":"2026-08-10","has_results":false,"results_due":false,"sponsor_name":"BioArctic AB","sponsor_slug":"bioarctic-ab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07321678","publication_url":"https://clinicaltrials.gov/study/NCT07321678","title":"A Phase II, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus","has_exemption":false,"start_date":"2026-01-22","completion_date":"2026-08-10","has_results":false,"results_due":false,"sponsor_name":"Ascletis Pharma (China) Co., Limited","sponsor_slug":"ascletis-pharma-china-co-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07451184","publication_url":"https://clinicaltrials.gov/study/NCT07451184","title":"Symptomology Changes With Systane PRO PF Versus Thealoz Duo","has_exemption":false,"start_date":"2026-02-23","completion_date":"2026-08-10","has_results":false,"results_due":false,"sponsor_name":"University of Waterloo","sponsor_slug":"university-of-waterloo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05886582","publication_url":"https://clinicaltrials.gov/study/NCT05886582","title":"Phase 2a Double-Blind Placebo-Controlled Trial of Transdermal Rotigotine as Adjunct to Behavioral Therapy for Cocaine Use Disorder","has_exemption":false,"start_date":"2023-09-11","completion_date":"2026-08-11","has_results":false,"results_due":false,"sponsor_name":"Virginia Commonwealth University","sponsor_slug":"virginia-commonwealth-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06035497","publication_url":"https://clinicaltrials.gov/study/NCT06035497","title":"A Phase 1/2 Study of the Safety, Tolerability, Pharmacokinetics, and Efficacy of BMS-986369 (Golcadomide) in Participants With Relapsed or Refractory T-cell Lymphomas in Japan (GOLSEEK-3)","has_exemption":false,"start_date":"2023-11-20","completion_date":"2026-08-11","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06433219","publication_url":"https://clinicaltrials.gov/study/NCT06433219","title":"An Open-label, Multicenter, Randomized Phase 2 Study of the ATR Inhibitor Tuvusertib in Combination With the PARP Inhibitor Niraparib or the ATM Inhibitor Lartesertib in Participants With BRCA Mutant and/or Homologous Recombination deficiency (HRD)-Positive Epithelial Ovarian Cancer That Progressed on Prior PARP Inhibitor Therapy (DDRiver EOC 302)","has_exemption":false,"start_date":"2024-10-30","completion_date":"2026-08-11","has_results":false,"results_due":false,"sponsor_name":"EMD Serono Research & Development Institute, Inc.","sponsor_slug":"emd-serono-research-development-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07774715","publication_url":"https://clinicaltrials.gov/study/NCT07774715","title":"Effect of Functional Electrical Stimulation (FES) on Handwriting Rehabilitation After Acquired Brain Injury (ABI)","has_exemption":false,"start_date":"2025-01-29","completion_date":"2026-08-11","has_results":false,"results_due":false,"sponsor_name":"Texas Woman's University","sponsor_slug":"texas-womans-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215767","publication_url":"https://clinicaltrials.gov/study/NCT07215767","title":"Clinical Study to Investigate the Antihypersensitivity Efficacy of a Novel Dentifrice","has_exemption":false,"start_date":"2025-09-16","completion_date":"2026-08-11","has_results":false,"results_due":false,"sponsor_name":"HALEON","sponsor_slug":"haleon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07000045","publication_url":"https://clinicaltrials.gov/study/NCT07000045","title":"Coronary Calcified Nodule Management With Rotational Atherectomy Plus Shockwave Intravascular Lithotripsy vs. Intravascular Lithotripsy Alone: A Prospective, Randomized Trial (NODULE-SHOCK)","has_exemption":false,"start_date":"2025-10-06","completion_date":"2026-08-11","has_results":false,"results_due":false,"sponsor_name":"Annapoorna Kini","sponsor_slug":"annapoorna-kini","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07091422","publication_url":"https://clinicaltrials.gov/study/NCT07091422","title":"A Split-Mouth Clinical Trial Evaluating the Bond Failure Rate of a New Etch-Free Orthodontic Adhesive","has_exemption":false,"start_date":"2025-11-05","completion_date":"2026-08-11","has_results":false,"results_due":false,"sponsor_name":"University of Maryland, Baltimore","sponsor_slug":"university-of-maryland-baltimore","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07268092","publication_url":"https://clinicaltrials.gov/study/NCT07268092","title":"Impact of Porcine Extracellular Matrix Nerve Wrap on Spinal Accessory Nerve in Patients Undergoing Neck Dissection for Head and Neck Cancer","has_exemption":false,"start_date":"2021-01-25","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05757570","publication_url":"https://clinicaltrials.gov/study/NCT05757570","title":"Open-Label Study to Assess the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Povetacicept in Subjects With Autoimmune Cytopenias (RUBY-4)","has_exemption":false,"start_date":"2023-07-03","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"Alpine Immune Sciences Inc, A Subsidiary of Vertex","sponsor_slug":"alpine-immune-sciences-inc-a-subsidiary-of-vertex","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06088199","publication_url":"https://clinicaltrials.gov/study/NCT06088199","title":"A Phase 3, Multi-center, Open-label, Single-arm Study to Assess the Safety of Apremilast (AMG 407) in Pediatric Participants From 6 Through 17 Years of Age With Mild to Moderate Plaque Psoriasis","has_exemption":false,"start_date":"2023-10-24","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06052059","publication_url":"https://clinicaltrials.gov/study/NCT06052059","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Program to Evaluate the Efficacy and Safety of MK-7240 in Participants With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2023-10-25","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06026371","publication_url":"https://clinicaltrials.gov/study/NCT06026371","title":"Fecal Microbiota Transplantation to Prevent Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation","has_exemption":false,"start_date":"2023-12-12","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05776953","publication_url":"https://clinicaltrials.gov/study/NCT05776953","title":"Evaluation of the Effects of Ketorolac 15mg IV Versus 30mg IV on Duration of Analgesia in Patients Who Present to the Emergency Department With Renal Colic","has_exemption":false,"start_date":"2023-12-21","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"Hackensack Meridian Health","sponsor_slug":"hackensack-meridian-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06018337","publication_url":"https://clinicaltrials.gov/study/NCT06018337","title":"A Phase 3, Randomized, Multi-center, Open-Label Study of DB-1303 Versus Investigator's Choice Chemotherapy in Human Epidermal Growth Factor Receptor 2 (HER2)-Low, Hormone Receptor Positive (HR+) Metastatic Breast Cancer Patients Whose Disease Has Progressed on Endocrine Therapy (ET) (DYNASTY-Breast02)","has_exemption":false,"start_date":"2024-01-18","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"DualityBio Inc.","sponsor_slug":"dualitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06158113","publication_url":"https://clinicaltrials.gov/study/NCT06158113","title":"Efficacy and Safety of Baricitinib for the Treatment of Oral Lichen Planus: A Proof-of-Concept Study","has_exemption":false,"start_date":"2024-03-13","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06206746","publication_url":"https://clinicaltrials.gov/study/NCT06206746","title":"A Prospective, Multicenter, Randomized, Pivotal Study of the May Health System in Transvaginal Ablation of Ovarian Tissue Under Ultrasound Guidance in Women With Infertility Due to Polycystic Ovary Syndrome","has_exemption":false,"start_date":"2024-03-25","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"May Health","sponsor_slug":"may-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06213454","publication_url":"https://clinicaltrials.gov/study/NCT06213454","title":"Transversus Abdominis Plane Block Compared to Local Anesthetic Wound Infiltration in Gynecologic Oncology Surgery","has_exemption":false,"start_date":"2024-03-26","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06368726","publication_url":"https://clinicaltrials.gov/study/NCT06368726","title":"Results of the Application of 80 Sessions of tDCS for 12 Months in Children Between 6 and 11 Years Old With Autism Spectrum Disorder With Rare Diseases, Genetic Problems or PANDAS","has_exemption":false,"start_date":"2024-04-01","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"Spanish Foundation for Neurometrics Development","sponsor_slug":"spanish-foundation-for-neurometrics-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06897358","publication_url":"https://clinicaltrials.gov/study/NCT06897358","title":"A Study to Assess Safety and Tolerability, and Explore Efficacy of Leniolisib for Immune Dysregulation in Common Variable Immunodeficiency (CVID)","has_exemption":false,"start_date":"2025-02-12","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"Pharming Technologies B.V.","sponsor_slug":"pharming-technologies-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06901505","publication_url":"https://clinicaltrials.gov/study/NCT06901505","title":"A Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy of Three Times Weekly Vadadustat Compared to Standard of Care ESA in Patients With Anemia of CKD Receiving In-Center Hemodialysis","has_exemption":false,"start_date":"2025-07-24","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"Akebia Therapeutics","sponsor_slug":"akebia-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07109869","publication_url":"https://clinicaltrials.gov/study/NCT07109869","title":"Safety and Efficacy Study to Assess 600 mg Boric Acid Vaginal Inserts With 7- or 14-Days Treatment of Vulvovaginal Candidiasis (VVC)","has_exemption":false,"start_date":"2025-08-08","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"pH-D Feminine Health LLC","sponsor_slug":"ph-d-feminine-health-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07213635","publication_url":"https://clinicaltrials.gov/study/NCT07213635","title":"Effect of Paracervical Block on Postoperative Opioid Use in Vaginal Hysterectomy for Prolapse: a Randomized, Placebo-Controlled Trial","has_exemption":false,"start_date":"2025-10-20","completion_date":"2026-08-12","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04788823","publication_url":"https://clinicaltrials.gov/study/NCT04788823","title":"The Impact of Prednisone on Semen Parameters and Pregnancy Rates Post Vasectomy Reversal: A Randomized, Controlled Trial","has_exemption":false,"start_date":"2021-02-24","completion_date":"2026-08-13","has_results":false,"results_due":false,"sponsor_name":"Charitable Union for the Research and Education of Peyronie's Disease","sponsor_slug":"charitable-union-for-the-research-and-education-of-peyronies-disease","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05715229","publication_url":"https://clinicaltrials.gov/study/NCT05715229","title":"A Multicenter Phase II Randomized Trial Of Immunotherapy Versus Chemotherapy Guided By Circulating Tumor DNA-Based Molecular Response On Patients With Metastatic NSCLC","has_exemption":false,"start_date":"2023-09-29","completion_date":"2026-08-13","has_results":false,"results_due":false,"sponsor_name":"Hackensack Meridian Health","sponsor_slug":"hackensack-meridian-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915922","publication_url":"https://clinicaltrials.gov/study/NCT06915922","title":"Therapeutic Neodymium-doped Yttrium-Aluminum-Garnet (Nd:YAG) Laser Vitreolysis for Vitreous Floaters - A Study to Quantify Visual Quality of Life, Vitreous Structure, and Vision Before and After Nd:YAG Laser Vitreolysis in Patients With Vision Degrading Myodesopsia","has_exemption":false,"start_date":"2023-10-17","completion_date":"2026-08-13","has_results":false,"results_due":false,"sponsor_name":"VMR Consulting, Inc.","sponsor_slug":"vmr-consulting-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06809595","publication_url":"https://clinicaltrials.gov/study/NCT06809595","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, 12-Week Study (Part A) With a 40 Week Open-label Extension (Part B) Evaluating the Efficacy and Safety of Oral MM120 Compared to Placebo in the Treatment of Adults With Generalized Anxiety Disorder - Panorama","has_exemption":false,"start_date":"2025-01-29","completion_date":"2026-08-13","has_results":false,"results_due":false,"sponsor_name":"Definium Therapeutics US, Inc.","sponsor_slug":"definium-therapeutics-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06926842","publication_url":"https://clinicaltrials.gov/study/NCT06926842","title":"A Randomized, Double-Blind, Phase 2 Trial of Once-Weekly Petrelintide Compared With Placebo in Participants With Overweight or Obesity and Type 2 Diabetes","has_exemption":false,"start_date":"2025-04-22","completion_date":"2026-08-13","has_results":false,"results_due":false,"sponsor_name":"Zealand Pharma","sponsor_slug":"zealand-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05630235","publication_url":"https://clinicaltrials.gov/study/NCT05630235","title":"Effects of a Hemp-derived Cannabidiol and Cannabidiolic-acid Oral Extract on Resting-state Electroencephalography and Neuropathic Pain Symptoms in People With Spinal Cord Injury","has_exemption":false,"start_date":"2025-06-16","completion_date":"2026-08-13","has_results":false,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07187388","publication_url":"https://clinicaltrials.gov/study/NCT07187388","title":"The Impact of Transcutaneous Electrical Stimulation on Facial Pain, Jaw Mobility, and Oral Health in Individuals With Motor Neuron Disease.","has_exemption":false,"start_date":"2026-04-02","completion_date":"2026-08-13","has_results":false,"results_due":false,"sponsor_name":"Nova Southeastern University","sponsor_slug":"nova-southeastern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02392572","publication_url":"https://clinicaltrials.gov/study/NCT02392572","title":"Phase I/II Study of Oral ONC201 in Patients With Relapsed or Refractory Acute Leukemias and High-Risk Myelodysplastic Syndromes","has_exemption":false,"start_date":"2015-11-03","completion_date":"2026-08-14","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05902533","publication_url":"https://clinicaltrials.gov/study/NCT05902533","title":"REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation","has_exemption":false,"start_date":"2023-08-14","completion_date":"2026-08-14","has_results":false,"results_due":false,"sponsor_name":"University of Cincinnati","sponsor_slug":"university-of-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06748157","publication_url":"https://clinicaltrials.gov/study/NCT06748157","title":"Non-Invasive Median Nerve Stimulation to Attenuate Atrial Tachyarrhythmias After Catheter Ablation for Atrial Fibrillation","has_exemption":false,"start_date":"2024-10-02","completion_date":"2026-08-14","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06926660","publication_url":"https://clinicaltrials.gov/study/NCT06926660","title":"A Phase II Randomised, Double-blind, Parallel-group, Multicentre, International Trial to Investigate the Safety and Efficacy of Vicadrostat and Empagliflozin Administered With Simultaneous vs Staggered Initiation in Participants With Chronic Kidney Disease at Risk of Kidney Disease Progression","has_exemption":false,"start_date":"2025-07-18","completion_date":"2026-08-14","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07209475","publication_url":"https://clinicaltrials.gov/study/NCT07209475","title":"A Randomized Controlled Multicenter Trial, Examining the Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.","has_exemption":false,"start_date":"2025-08-14","completion_date":"2026-08-14","has_results":false,"results_due":false,"sponsor_name":"Royal Biologics","sponsor_slug":"royal-biologics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03665831","publication_url":"https://clinicaltrials.gov/study/NCT03665831","title":"Treatment of Comorbid Depression and Cognitive Impairment in Older Adults With Neurocognitive Disorders Using Deep Transcranial Magnetic Stimulation (dTMS)","has_exemption":false,"start_date":"2018-10-23","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"Rotman Research Institute at Baycrest","sponsor_slug":"rotman-research-institute-at-baycrest","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04491370","publication_url":"https://clinicaltrials.gov/study/NCT04491370","title":"Safety and Tolerability of Myeloablative Conditioning and Autologous Stem Cell Transplantation Followed by Polatuzumab Vedotin (PV) Immunoconjugate Therapy in Patients With B-cell Non-Hodgkin and Hodgkin Lymphoma","has_exemption":false,"start_date":"2021-08-01","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"New York Medical College","sponsor_slug":"new-york-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06006637","publication_url":"https://clinicaltrials.gov/study/NCT06006637","title":"Integrated Platform for Measuring and Reducing Symptoms of Autism Spectrum Disorder","has_exemption":false,"start_date":"2023-10-17","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"State University of New York - Upstate Medical University","sponsor_slug":"state-university-of-new-york-upstate-medical-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06039566","publication_url":"https://clinicaltrials.gov/study/NCT06039566","title":"A Trial Evaluating the Impact of N-acetylcysteine on Opioid Use in Patients Undergoing a Hysterectomy Procedure","has_exemption":false,"start_date":"2023-11-30","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06662994","publication_url":"https://clinicaltrials.gov/study/NCT06662994","title":"High Dose Aflibercept in Diabetic Macular Edema in Patients With Previous Vitrectomy","has_exemption":false,"start_date":"2025-07-07","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"Retina Consultants of Orange County","sponsor_slug":"retina-consultants-of-orange-county","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282080","publication_url":"https://clinicaltrials.gov/study/NCT07282080","title":"Discover Better Body Composition With Green Light!","has_exemption":false,"start_date":"2025-08-15","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06990906","publication_url":"https://clinicaltrials.gov/study/NCT06990906","title":"BENCHMARK SPERM: A Prospective, Randomized Controlled Study Evaluating the Safety and Clinical Efficacy of the BAIBYS™ System in Intracytoplasmic Sperm Injection (ICSI)","has_exemption":false,"start_date":"2026-03-15","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"BAIBYS Fertility","sponsor_slug":"baibys-fertility","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07655180","publication_url":"https://clinicaltrials.gov/study/NCT07655180","title":"A Phase 3, Randomized, Double-Blind Study to Evaluate the Safety, Serum Virus Neutralizing Antibody Responses, and Pharmacokinetics of VYD2311, a COVID-19 Vaccine, and Coadministered VYD2311 With a COVID-19 Vaccine","has_exemption":false,"start_date":"2026-06-08","completion_date":"2026-08-15","has_results":false,"results_due":false,"sponsor_name":"Invivyd, Inc.","sponsor_slug":"invivyd-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03339128","publication_url":"https://clinicaltrials.gov/study/NCT03339128","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Safety and Efficacy of Eluxadoline in Pediatric Participants (Age 6 to 17 Years) With Irritable Bowel Syndrome With Diarrhea (IBS-D)","has_exemption":false,"start_date":"2017-11-15","completion_date":"2026-08-17","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05325996","publication_url":"https://clinicaltrials.gov/study/NCT05325996","title":"Evaluating Effectiveness of Home Testing Devises for Assisting in Management of Glaucoma Outside a Clinical Setting During a 2 Year Period.","has_exemption":false,"start_date":"2022-04-15","completion_date":"2026-08-17","has_results":false,"results_due":false,"sponsor_name":"Wills Eye","sponsor_slug":"wills-eye","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04605913","publication_url":"https://clinicaltrials.gov/study/NCT04605913","title":"A Phase I/Ib Pilot Trial, Single Arm, Open Label, of Protein-Bound Paclitaxel, Cisplatin, and Gemcitabine (GCN) Combined With Tumor Treatment Fields (TTF) in Patient With Metastatic Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2022-04-25","completion_date":"2026-08-17","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06117501","publication_url":"https://clinicaltrials.gov/study/NCT06117501","title":"Nerve Protection Evaluation: Revision Cubital Tunnel Syndrome Decompression","has_exemption":false,"start_date":"2023-10-19","completion_date":"2026-08-17","has_results":false,"results_due":false,"sponsor_name":"Axogen Corporation","sponsor_slug":"axogen-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05984277","publication_url":"https://clinicaltrials.gov/study/NCT05984277","title":"A Phase III, Two-Arm, Parallel, Randomized, Multi-Center, Open-Label, Global Study to Determine the Efficacy of Volrustomig (MEDI5752) Plus Chemotherapy Versus Pembrolizumab Plus Chemotherapy for First-Line Treatment of Patients With Metastatic Non-Small Cell Lung Cancer (mNSCLC).","has_exemption":false,"start_date":"2023-10-24","completion_date":"2026-08-17","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06029439","publication_url":"https://clinicaltrials.gov/study/NCT06029439","title":"Long-term Study to Assess the Safety and Effectiveness of NMRA-335140 in Participants With Major Depressive Disorder","has_exemption":false,"start_date":"2023-11-10","completion_date":"2026-08-17","has_results":false,"results_due":false,"sponsor_name":"Neumora Therapeutics, Inc.","sponsor_slug":"neumora-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06780332","publication_url":"https://clinicaltrials.gov/study/NCT06780332","title":"A Phase 4 Study to Evaluate the Impact of a Rapid Drug Desensitization (RDD) Protocol for Adults With Phenylketonuria and Experiencing Hypersensitivity Reactions to Palynziq","has_exemption":false,"start_date":"2025-02-07","completion_date":"2026-08-17","has_results":false,"results_due":false,"sponsor_name":"BioMarin Pharmaceutical","sponsor_slug":"biomarin-pharmaceutical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06769659","publication_url":"https://clinicaltrials.gov/study/NCT06769659","title":"A Single-center, Double-blind, Placebo-controlled Crossover Study Evaluating NPT 2042 Versus Placebo in Subjects Aged 16-75 Years With Genetic Generalized Epilepsy (GGE) and Absence Seizures","has_exemption":false,"start_date":"2025-03-11","completion_date":"2026-08-17","has_results":false,"results_due":false,"sponsor_name":"NeuroPro Therapeutics, Inc.","sponsor_slug":"neuropro-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07016412","publication_url":"https://clinicaltrials.gov/study/NCT07016412","title":"A Phase IIb, Randomized, Double-blind, Placebo- Controlled, Parallel Group Study to Assess the Efficacy and Safety of Ensifentrine-glycopyrrolate Fixed-dose Combination at Two Dose Levels Compared to Glycopyrrolate or Ensifentrine Monotherapy in Subjects With COPD","has_exemption":false,"start_date":"2025-07-31","completion_date":"2026-08-17","has_results":false,"results_due":false,"sponsor_name":"Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA","sponsor_slug":"verona-pharma-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03461120","publication_url":"https://clinicaltrials.gov/study/NCT03461120","title":"Improving Postamputation Functioning by Decreasing Phantom Limb Pain and Opioid Use With Perioperative Continuous Peripheral Nerve Blocks: A Multicenter RCT","has_exemption":false,"start_date":"2018-03-23","completion_date":"2026-08-18","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07147166","publication_url":"https://clinicaltrials.gov/study/NCT07147166","title":"Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy: A Randomized Self-Controlled Trial","has_exemption":false,"start_date":"2025-02-03","completion_date":"2026-08-18","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06619236","publication_url":"https://clinicaltrials.gov/study/NCT06619236","title":"A Phase 3 Randomized, Open-label Study of Rinatabart Sesutecan (Rina-S) Versus Treatment of Investigator's Choice (IC) in Patients With Platinum Resistant Ovarian Cancer","has_exemption":false,"start_date":"2025-02-07","completion_date":"2026-08-18","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06864169","publication_url":"https://clinicaltrials.gov/study/NCT06864169","title":"A Phase 2 Nonrandomized, Open-label, Multisite Study to Evaluate the Safety and Efficacy of Raludotatug Deruxtecan in Participants With Gastrointestinal Cancers","has_exemption":false,"start_date":"2025-04-01","completion_date":"2026-08-18","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05230537","publication_url":"https://clinicaltrials.gov/study/NCT05230537","title":"A Randomized, Participant and Investigator Masked, Placebo-controlled, Multicenter, Proof-of-concept Study to Assess the Safety and Efficacy of LNP023 (Iptacopan) in Patients With Early and Intermediate Age-related Macular Degeneration","has_exemption":false,"start_date":"2022-02-17","completion_date":"2026-08-19","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05796570","publication_url":"https://clinicaltrials.gov/study/NCT05796570","title":"A Pilot Study to Evaluate the Feasibility of Post-Hematopoietic Stem Cell Transplant Prophylaxis With Decitabine Combined With Filgrastim for Children and Young Adults With AML, MDS and Related Myeloid Malignancies","has_exemption":false,"start_date":"2023-04-19","completion_date":"2026-08-19","has_results":false,"results_due":false,"sponsor_name":"Franziska Wachter","sponsor_slug":"franziska-wachter","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05690984","publication_url":"https://clinicaltrials.gov/study/NCT05690984","title":"Combination Post-transplant Consolidation Therapy With Isatuximab, Lenalidomide, Dexamethasone (IsaRD) in Multiple Myeloma Patients With Persistent Marrow Minimal Residual Disease (Elimination of MRD After Transplant; E-MAT)","has_exemption":false,"start_date":"2023-06-26","completion_date":"2026-08-19","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06618612","publication_url":"https://clinicaltrials.gov/study/NCT06618612","title":"A Multicenter, Prospective, Randomized Controlled Modified Platform Trial Assessing the Efficacy of a Purified Native Type 1 Collagen Extracellular Matrix With Polyhexamethylene Biguanide Antimicrobial (PCMP) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers","has_exemption":false,"start_date":"2024-08-19","completion_date":"2026-08-19","has_results":false,"results_due":false,"sponsor_name":"Organogenesis","sponsor_slug":"organogenesis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06694805","publication_url":"https://clinicaltrials.gov/study/NCT06694805","title":"A Phase 3b, Open Label, Randomized, standard-of Care Control Arm, Multicenter, Superiority Study Evaluating the Efficacy, Safety, and Tolerability of Injectable CAB LA + RPV LA in Viremic Participants Living With HIV-1 (CROWN)","has_exemption":false,"start_date":"2024-12-02","completion_date":"2026-08-19","has_results":false,"results_due":false,"sponsor_name":"ViiV Healthcare","sponsor_slug":"viiv-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07213986","publication_url":"https://clinicaltrials.gov/study/NCT07213986","title":"Pilot Trial of the Vibrant Capsule for Spinal Cord Injury Neurogenic Bowel Dysfunction","has_exemption":false,"start_date":"2026-01-06","completion_date":"2026-08-19","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01684397","publication_url":"https://clinicaltrials.gov/study/NCT01684397","title":"A Phase I/II Trial of Pazopanib Alternating With Bevacizumab in Treatment-Naive Metastatic Clear Cell Renal Cell Carcinoma Patients","has_exemption":false,"start_date":"2012-11-21","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03131908","publication_url":"https://clinicaltrials.gov/study/NCT03131908","title":"Phase I/II Study of the Selective PI3K-Beta Inhibitor GSK2636771 in Combination With Pembrolizumab in Patients With Metastatic Melanoma and PTEN Loss","has_exemption":false,"start_date":"2017-07-17","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04474132","publication_url":"https://clinicaltrials.gov/study/NCT04474132","title":"Feasibility Study for Finger Prick Testing of Presence of Current and or Previous T. Gondii Infection","has_exemption":false,"start_date":"2020-08-13","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04996823","publication_url":"https://clinicaltrials.gov/study/NCT04996823","title":"Phase 2 Study of Axitinib + Ipilimumab in Advanced Melanoma","has_exemption":false,"start_date":"2021-08-04","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04898504","publication_url":"https://clinicaltrials.gov/study/NCT04898504","title":"EXtended CriteriA Treatment for LIver Metastases With Heavy Tumour BURden 1 + 2","has_exemption":false,"start_date":"2021-08-23","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"Oslo University Hospital","sponsor_slug":"oslo-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05643534","publication_url":"https://clinicaltrials.gov/study/NCT05643534","title":"A 12-Week, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Assess the Safety and Efficacy of Tenapanor for the Treatment of Irritable Bowel Syndrome With Constipation (IBS-C) in Pediatric Patients 12 to Less Than 18 Years Old","has_exemption":false,"start_date":"2022-11-15","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"Ardelyx","sponsor_slug":"ardelyx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05482516","publication_url":"https://clinicaltrials.gov/study/NCT05482516","title":"Evaluating Novel Therapies and ctDNA as a Marker in Curatively-Treated Gastrointestinal Cancers With Microscopic Residual Disease","has_exemption":false,"start_date":"2023-03-29","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06050122","publication_url":"https://clinicaltrials.gov/study/NCT06050122","title":"A Multicenter, Randomized, Double Blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Gel 2% for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Gorlin Syndrome","has_exemption":false,"start_date":"2024-03-17","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"Sol-Gel Technologies, Ltd.","sponsor_slug":"sol-gel-technologies-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06498479","publication_url":"https://clinicaltrials.gov/study/NCT06498479","title":"ARTEMIS-008：A Multicenter, Randomized, Open-label, Phase 3 Study of HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer After Platinum-based First-line Chemotherapy","has_exemption":false,"start_date":"2024-07-04","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"Hansoh BioMedical R&D Company","sponsor_slug":"hansoh-biomedical-rd-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07303998","publication_url":"https://clinicaltrials.gov/study/NCT07303998","title":"Feasibility and Effect of Remotely Supervised Transcranial Direct Current Stimulation With Chair Yoga for Chronic Knee Pain Management in Older Adults With Alzheimer's Disease and Related Dementias.","has_exemption":false,"start_date":"2025-03-04","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04107077","publication_url":"https://clinicaltrials.gov/study/NCT04107077","title":"A Phase IIa Study of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and PD-L1 Expression in Gastric Cancer With Peritoneal Metastases","has_exemption":false,"start_date":"2025-09-09","completion_date":"2026-08-20","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05206331","publication_url":"https://clinicaltrials.gov/study/NCT05206331","title":"Contrast Enhanced Mammography (CEM) to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study","has_exemption":false,"start_date":"2022-02-01","completion_date":"2026-08-21","has_results":false,"results_due":false,"sponsor_name":"Margarita Louise Zuley","sponsor_slug":"margarita-louise-zuley","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05285566","publication_url":"https://clinicaltrials.gov/study/NCT05285566","title":"A Phase IV Randomized, Single-Blind Trial of Liposomal Bupivacaine (Exparel®) for Pain Control in Costal Cartilage Harvest","has_exemption":false,"start_date":"2022-05-04","completion_date":"2026-08-21","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05796453","publication_url":"https://clinicaltrials.gov/study/NCT05796453","title":"Long-term Evaluation of Safety and Performance of Clareon Presbyopia-Correcting Intraocular Lenses (IOLs)","has_exemption":false,"start_date":"2023-09-19","completion_date":"2026-08-21","has_results":false,"results_due":false,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07220629","publication_url":"https://clinicaltrials.gov/study/NCT07220629","title":"A Phase 2a Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Explore the Safety and Efficacy of NT-0796 as an Adjunct to Semaglutide Plus a Reduced Calorie Diet and Increased Physical Activity in Participants With Obesity","has_exemption":false,"start_date":"2025-10-02","completion_date":"2026-08-21","has_results":false,"results_due":false,"sponsor_name":"Rezera (formerly NodThera Limited)","sponsor_slug":"rezera-formerly-nodthera-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07284381","publication_url":"https://clinicaltrials.gov/study/NCT07284381","title":"A Multicenter, Double-masked, Randomized Study to Compare the Efficacy and Safety of the ABBV-444 Tear Formulation With REFRESH OPTIVE® Unit Dose in Patients With Dry Eye Disease","has_exemption":false,"start_date":"2025-12-15","completion_date":"2026-08-21","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07120763","publication_url":"https://clinicaltrials.gov/study/NCT07120763","title":"Pain Control Alternatives in Pediatric Patients With Distal Radius Fractures","has_exemption":false,"start_date":"2025-08-22","completion_date":"2026-08-22","has_results":false,"results_due":false,"sponsor_name":"State University of New York at Buffalo","sponsor_slug":"state-university-of-new-york-at-buffalo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221617","publication_url":"https://clinicaltrials.gov/study/NCT07221617","title":"Oral Methadone In Cardiac Surgery","has_exemption":false,"start_date":"2026-01-13","completion_date":"2026-08-22","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06686043","publication_url":"https://clinicaltrials.gov/study/NCT06686043","title":"A Phase 2 Study of HPV L1 Vaccine in Combination With Imiquimod and Metformin in Cervical, Vaginal, and Vulvar Cancers","has_exemption":false,"start_date":"2024-08-23","completion_date":"2026-08-23","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04232657","publication_url":"https://clinicaltrials.gov/study/NCT04232657","title":"Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI","has_exemption":false,"start_date":"2021-03-01","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05389449","publication_url":"https://clinicaltrials.gov/study/NCT05389449","title":"A Long-term Extension (LTE) Study to Characterize the Safety and Efficacy of Danicopan as an Add-on Therapy to a Complement Component 5 Inhibitor (C5i) in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Previously Treated With Danicopan in an Alexion-sponsored Clinical Study","has_exemption":false,"start_date":"2022-10-28","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05264623","publication_url":"https://clinicaltrials.gov/study/NCT05264623","title":"A Study to Investigate the Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism","has_exemption":false,"start_date":"2022-11-15","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"Bausch & Lomb Incorporated","sponsor_slug":"bausch-lomb-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05538533","publication_url":"https://clinicaltrials.gov/study/NCT05538533","title":"A Phase I Study of Hypofractionated Preoperative Radiation for Head and Neck Cancers (HyPR-HN)","has_exemption":false,"start_date":"2023-01-06","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05006404","publication_url":"https://clinicaltrials.gov/study/NCT05006404","title":"Autus Size-Adjustable Valve for Surgical Pulmonary Valve Replacement Pivotal Study","has_exemption":false,"start_date":"2024-02-05","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06225830","publication_url":"https://clinicaltrials.gov/study/NCT06225830","title":"Utilization of Robotic EksoSkeleton to Achieve High Dosing, Intensity, and Complexity of Gait in Treatment of People With Parkinson's Disease","has_exemption":false,"start_date":"2024-06-04","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"Albert Einstein Healthcare Network","sponsor_slug":"albert-einstein-healthcare-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06161441","publication_url":"https://clinicaltrials.gov/study/NCT06161441","title":"A Phase 2 Peri-Operative Trial of Fianlimab and Cemiplimab in Combination With Chemotherapy Versus Cemiplimab in Combination With Chemotherapy in Patients With Resectable Early Stage (Stage II to IIIB [N2]) NSCLC","has_exemption":false,"start_date":"2024-07-16","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05632315","publication_url":"https://clinicaltrials.gov/study/NCT05632315","title":"A Phase II Randomized Trial to Evaluate the Impact of Fecal Microbiota Transplantation Using the Penn Microbiome Therapy Products on Recipient and Environmental Colonization With Multidrug-Resistant Organisms","has_exemption":false,"start_date":"2024-08-19","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06791122","publication_url":"https://clinicaltrials.gov/study/NCT06791122","title":"A Multicenter, Pragmatic Study to Evaluate Clinical Effectiveness, Engagement With the Study App, Healthcare Resource Utilization, and Safety of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia","has_exemption":false,"start_date":"2025-01-23","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07204964","publication_url":"https://clinicaltrials.gov/study/NCT07204964","title":"A Phase 2a Randomized, Observer-Blind, Study to Evaluate the Immunogenicity and Safety of mRNA-Based Multivalent Seasonal Influenza Vaccine Candidates in Adults 18 Years of Age and Older","has_exemption":false,"start_date":"2025-10-07","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06330493","publication_url":"https://clinicaltrials.gov/study/NCT06330493","title":"Prospective Multi-Center Randomized Controlled Trial to Evaluate the Safety and Efficacy of AcoArt Litos Paclitaxel Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Versus Non-Coated Standard Balloon Angioplasty for the Treatment of Infrapopliteal Obstructions in Patients With Chronic Limb-Threatening Ischemia","has_exemption":false,"start_date":"2025-10-10","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"Acotec Scientific Co., Ltd","sponsor_slug":"acotec-scientific-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214272","publication_url":"https://clinicaltrials.gov/study/NCT07214272","title":"A Phase 4 Clinical Study to Investigate the Effectiveness and Safety of Skin Resurfacing Procedures Using the Next Generation Fraxel® FTX Laser System in Participants With Dyschromia, Cutaneous Lesions, and Periorbital Rhytids","has_exemption":false,"start_date":"2025-10-17","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07413705","publication_url":"https://clinicaltrials.gov/study/NCT07413705","title":"Safety and Efficacy of the Combined BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women","has_exemption":false,"start_date":"2025-11-20","completion_date":"2026-08-24","has_results":false,"results_due":false,"sponsor_name":"BTL Industries Ltd.","sponsor_slug":"btl-industries-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03793140","publication_url":"https://clinicaltrials.gov/study/NCT03793140","title":"A Phase II Clinical Trial of CPI-613 in Patients With Relapsed or Refractory Burkitt Lymphoma/Leukemia or High-grade B-cell Lymphoma With Rearrangements of MYC and BCL2 and/or BCL6","has_exemption":false,"start_date":"2018-12-31","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04567303","publication_url":"https://clinicaltrials.gov/study/NCT04567303","title":"A Three-part, Phase I/II Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Zifibancimig Following Intravitreal Administration of Multiple Ascending Doses and Continuous Delivery From the Port Delivery in Patients With Neovascular Age-related Macular Degeneration","has_exemption":false,"start_date":"2020-10-28","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04752813","publication_url":"https://clinicaltrials.gov/study/NCT04752813","title":"A Study of BPM31510 With Vitamin K1 in Subjects With Newly Diagnosed Glioblastoma (GB)","has_exemption":false,"start_date":"2022-08-22","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"BPGbio","sponsor_slug":"bpgbio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05634499","publication_url":"https://clinicaltrials.gov/study/NCT05634499","title":"A Phase II, Single-Arm Study of Giredestrant in Patients With Grade 1 Endometrial Cancer","has_exemption":false,"start_date":"2023-06-27","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05804669","publication_url":"https://clinicaltrials.gov/study/NCT05804669","title":"A Phase 1b/2a Open-label Multiple-ascending Dose Exploratory Study of CRN04894 in ACTH-dependent Cushing's Syndrome (Cushing's Disease or Ectopic ACTH Syndrome)","has_exemption":false,"start_date":"2023-10-12","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"Crinetics Pharmaceuticals Inc.","sponsor_slug":"crinetics-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06676930","publication_url":"https://clinicaltrials.gov/study/NCT06676930","title":"Impact of Computer Aided Detection on Trainee Polyp Miss Rates Using a Tandem Colonoscopy Design","has_exemption":false,"start_date":"2024-09-10","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06790966","publication_url":"https://clinicaltrials.gov/study/NCT06790966","title":"A Phase 3 Open-Label, Randomized Study of PDS0101 and Pembrolizumab vs Pembrolizumab Alone in First-Line Treatment of Unresectable Recurrent and/or Metastatic HPV16+ Head and Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2025-05-30","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"PDS Biotechnology Corp.","sponsor_slug":"pds-biotechnology-corp","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281989","publication_url":"https://clinicaltrials.gov/study/NCT07281989","title":"Sound Stops Stress Study: Evaluating the WAVwatch Effect","has_exemption":false,"start_date":"2025-08-25","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07543380","publication_url":"https://clinicaltrials.gov/study/NCT07543380","title":"A PHASE 3, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS (RSV) PREFUSION F SUBUNIT VACCINE IN ADULTS CONSIDERED AT HIGH RISK OF SEVERE RSV DISEASE IN JAPAN","has_exemption":false,"start_date":"2026-05-11","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07414771","publication_url":"https://clinicaltrials.gov/study/NCT07414771","title":"A Medical Device Pilot Study to Evaluate the Safety and Usability of the Inga Catheter in Labor Induction","has_exemption":false,"start_date":"2026-07-01","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"Aalto University","sponsor_slug":"aalto-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07214948","publication_url":"https://clinicaltrials.gov/study/NCT07214948","title":"An Open, Parallel-group, Randomized, Early Feasibility Trial to Evaluate the Initial Safety and Performance of the INGA Catheter in Labor Induction","has_exemption":false,"start_date":"2026-07-03","completion_date":"2026-08-25","has_results":false,"results_due":false,"sponsor_name":"Aalto University","sponsor_slug":"aalto-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03716531","publication_url":"https://clinicaltrials.gov/study/NCT03716531","title":"PACER (Pancreatic AdenoCarcinoma With Electron Intraoperative Radiation Therapy): A Phase II Study of Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement","has_exemption":false,"start_date":"2019-03-19","completion_date":"2026-08-26","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03845712","publication_url":"https://clinicaltrials.gov/study/NCT03845712","title":"A Phase 2 Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With Thymidine Kinase 2 Deficiency (TK2)","has_exemption":false,"start_date":"2019-07-05","completion_date":"2026-08-26","has_results":false,"results_due":false,"sponsor_name":"UCB BIOSCIENCES, Inc.","sponsor_slug":"ucb-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05077735","publication_url":"https://clinicaltrials.gov/study/NCT05077735","title":"Stereotactic Biopsy Split-Course Radiation Therapy - Diffuse Midline Glioma (SPORT-DMG)","has_exemption":false,"start_date":"2021-10-11","completion_date":"2026-08-26","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05659576","publication_url":"https://clinicaltrials.gov/study/NCT05659576","title":"Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation","has_exemption":false,"start_date":"2022-12-13","completion_date":"2026-08-26","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06232577","publication_url":"https://clinicaltrials.gov/study/NCT06232577","title":"5x-Multiplier vs 3-Tier Model for Discharge Opioid Prescriptions After Intra-abdominal Cancer Surgery: A Randomized Clinical Trial","has_exemption":false,"start_date":"2024-03-27","completion_date":"2026-08-26","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07144293","publication_url":"https://clinicaltrials.gov/study/NCT07144293","title":"Improving Physical Ability and Cellular Senescence Elimination in HIV","has_exemption":false,"start_date":"2025-12-04","completion_date":"2026-08-26","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03554356","publication_url":"https://clinicaltrials.gov/study/NCT03554356","title":"Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)","has_exemption":false,"start_date":"2018-09-04","completion_date":"2026-08-27","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05413850","publication_url":"https://clinicaltrials.gov/study/NCT05413850","title":"An Open-label, Multicentre, Integrated Phase 1 & 2 Study to Evaluate the Safety, Tolerability, Radiation Dosimetry and Anti-tumour Activity of Lutetium (177Lu) rhPSMA-10.1 Injection in Men With Metastatic Castrate-resistant Prostate Cancer","has_exemption":false,"start_date":"2022-07-20","completion_date":"2026-08-27","has_results":false,"results_due":false,"sponsor_name":"Blue Earth Therapeutics Ltd","sponsor_slug":"blue-earth-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06260722","publication_url":"https://clinicaltrials.gov/study/NCT06260722","title":"A Phase 3, Randomized, Multicenter, Open-label Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared With Semaglutide Once Weekly in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin With or Without SGLT2 Inhibitor (TRANSCEND-T2D-2)","has_exemption":false,"start_date":"2024-02-21","completion_date":"2026-08-27","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06195982","publication_url":"https://clinicaltrials.gov/study/NCT06195982","title":"Acute Effects of Ketones in Heart Failure With Reduced Ejection Fraction","has_exemption":false,"start_date":"2024-03-06","completion_date":"2026-08-27","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06822049","publication_url":"https://clinicaltrials.gov/study/NCT06822049","title":"Improving Efficiency, Quality, and Equity: Randomized Controlled Evaluations of Remote vs. In-Person Clinical Trial Methods; Remote vs. In-Person Study Evaluation (RISE) Trials","has_exemption":false,"start_date":"2025-03-10","completion_date":"2026-08-27","has_results":false,"results_due":false,"sponsor_name":"State University of New York at Buffalo","sponsor_slug":"state-university-of-new-york-at-buffalo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215780","publication_url":"https://clinicaltrials.gov/study/NCT07215780","title":"SORE Study: Sitz Baths After Urogynecologic Reconstruction","has_exemption":false,"start_date":"2025-10-28","completion_date":"2026-08-27","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07413692","publication_url":"https://clinicaltrials.gov/study/NCT07413692","title":"Safety and Efficacy of the Combined BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Urinary Incontinence Among Postpartum Women and Women up to Five Years After Childbirth","has_exemption":false,"start_date":"2025-11-25","completion_date":"2026-08-27","has_results":false,"results_due":false,"sponsor_name":"BTL Industries Ltd.","sponsor_slug":"btl-industries-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03015896","publication_url":"https://clinicaltrials.gov/study/NCT03015896","title":"A Phase I/II Study of the PD-1 Antibody Nivolumab in Combination With Lenalidomide in Relapsed/Refractory Non-Hodgkin's Lymphoma (NHL) and Hodgkin's Disease (HD)","has_exemption":false,"start_date":"2017-02-14","completion_date":"2026-08-28","has_results":false,"results_due":false,"sponsor_name":"David Bond, MD","sponsor_slug":"david-bond-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03871075","publication_url":"https://clinicaltrials.gov/study/NCT03871075","title":"Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease: The INTERCEDE TRIAL","has_exemption":false,"start_date":"2019-01-02","completion_date":"2026-08-28","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04868838","publication_url":"https://clinicaltrials.gov/study/NCT04868838","title":"A Phase 2 Open-label Trial Evaluating the Efficacy and Safety of Daratumumab in Treatment of Patients With Active Lupus Nephritis","has_exemption":false,"start_date":"2021-04-20","completion_date":"2026-08-28","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04995523","publication_url":"https://clinicaltrials.gov/study/NCT04995523","title":"Phase I/II, Open-label, Dose Escalation and Dose Expansion Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Efficacy of AZD2936 Anti-TIGIT/Anti-PD-1 Bispecific Antibody in Participants With Advanced or Metastatic NSCLC","has_exemption":false,"start_date":"2021-09-14","completion_date":"2026-08-28","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04814693","publication_url":"https://clinicaltrials.gov/study/NCT04814693","title":"A Prospective, Post-Market, Multicenter, Randomized Controlled Trial to Compare the Performance of the EndoRotor® System Versus Conventional Endoscopic Techniques for Direct Endoscopic Necrosectomy of Walled Off Necrosis - The RESOlVE Trial","has_exemption":false,"start_date":"2022-09-02","completion_date":"2026-08-28","has_results":false,"results_due":false,"sponsor_name":"Erasmus Medical Center","sponsor_slug":"erasmus-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05568095","publication_url":"https://clinicaltrials.gov/study/NCT05568095","title":"A Randomized, Open-Label, Multicenter Phase 3 Trial of Domvanalimab, Zimberelimab, and Chemotherapy Versus Nivolumab and Chemotherapy in Participants With Previously Untreated Locally Advanced Unresectable or Metastatic Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma","has_exemption":false,"start_date":"2022-11-21","completion_date":"2026-08-28","has_results":false,"results_due":false,"sponsor_name":"Arcus Biosciences, Inc.","sponsor_slug":"arcus-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05757713","publication_url":"https://clinicaltrials.gov/study/NCT05757713","title":"Single Arm, Open-label Study to Assess the Safety and Pharmacokinetics of a 14-day Regimen of Teplizumab in Pediatric Stage 2 Type 1 Diabetes (Participants <8 Years of Age With at Least Two Autoantibodies and Dysglycemia)","has_exemption":false,"start_date":"2023-07-25","completion_date":"2026-08-28","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07516808","publication_url":"https://clinicaltrials.gov/study/NCT07516808","title":"PRISM-NLM: Prostatectomy Intraoperative Surgical Margin Assessment With Non-linear Microscopy","has_exemption":false,"start_date":"2026-06-30","completion_date":"2026-08-28","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05254171","publication_url":"https://clinicaltrials.gov/study/NCT05254171","title":"A Randomized, Double-Blind, Placebo-Controlled Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Subjects Previously Untreated for Metastatic Pancreatic Ductal Adenocarcinoma","has_exemption":false,"start_date":"2022-08-08","completion_date":"2026-08-29","has_results":false,"results_due":false,"sponsor_name":"Panbela Therapeutics, Inc.","sponsor_slug":"panbela-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05849402","publication_url":"https://clinicaltrials.gov/study/NCT05849402","title":"Accelerated Intermittent Theta-Burst Stimulation (aiTBS) in Treatment-Resistant Depression of Bipolar II Disorder","has_exemption":false,"start_date":"2022-12-20","completion_date":"2026-08-29","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06400004","publication_url":"https://clinicaltrials.gov/study/NCT06400004","title":"A Phase III Crossover Study to Evaluate Bolus Versus Continuous Infusion of Lumason® in Patients With Suboptimal Unenhanced Echocardiography","has_exemption":false,"start_date":"2024-07-10","completion_date":"2026-08-29","has_results":false,"results_due":false,"sponsor_name":"Bracco Diagnostics, Inc","sponsor_slug":"bracco-diagnostics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282119","publication_url":"https://clinicaltrials.gov/study/NCT07282119","title":"Can EmeraldLED Reshape Your Body With Continued Use?","has_exemption":false,"start_date":"2025-08-29","completion_date":"2026-08-29","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04178005","publication_url":"https://clinicaltrials.gov/study/NCT04178005","title":"Cladribine Tablets After Treatment With Natalizumab (CLADRINA)","has_exemption":false,"start_date":"2020-02-19","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04278651","publication_url":"https://clinicaltrials.gov/study/NCT04278651","title":"Early Antenatal Support for Iron Deficiency Anemia: A Randomized Controlled Trial of Early Initiation of Intravenous Versus Oral Iron Therapy for Treatment of Iron Deficiency Anemia in Pregnancy","has_exemption":false,"start_date":"2021-09-29","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05446298","publication_url":"https://clinicaltrials.gov/study/NCT05446298","title":"Phase 2 Randomized Open-label Multicenter Study of Combination of ONC-392 and Pembrolizumab for the Treatment of Patients With Platinum Resistant Ovarian Cancer (PROC)","has_exemption":false,"start_date":"2022-12-22","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"OncoC4, Inc.","sponsor_slug":"oncoc4-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05806164","publication_url":"https://clinicaltrials.gov/study/NCT05806164","title":"Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence","has_exemption":false,"start_date":"2023-06-06","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Women and Infants Hospital of Rhode Island","sponsor_slug":"women-and-infants-hospital-of-rhode-island","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05901233","publication_url":"https://clinicaltrials.gov/study/NCT05901233","title":"Telerehabilitation With Remotely-Supervised tDCS in Progressive Aphasia","has_exemption":false,"start_date":"2023-07-10","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06152575","publication_url":"https://clinicaltrials.gov/study/NCT06152575","title":"A PHASE 3, OPEN-LABEL STUDY OF ELRANATAMAB MONOTHERAPY VERSUS ELOTUZUMAB, POMALIDOMIDE, DEXAMETHASONE (EPd) OR POMALIDOMIDE, BORTEZOMIB, DEXAMETHASONE (PVd) OR CARFILZOMIB, DEXAMETHASONE (Kd) IN PARTICIPANTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA WHO RECEIVED PRIOR ANTI-CD38 DIRECTED THERAPY","has_exemption":false,"start_date":"2024-02-08","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05671692","publication_url":"https://clinicaltrials.gov/study/NCT05671692","title":"Novel Intervention for Chronic Complex TBI in OEF/OIF/OND Veterans","has_exemption":false,"start_date":"2024-09-06","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Christine Marx, MD","sponsor_slug":"christine-marx-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06861478","publication_url":"https://clinicaltrials.gov/study/NCT06861478","title":"In-Hospital Morbidity Associated With Proton Pump Inhibitors in Acute Variceal Bleeding and Chronic Liver Disease Treatment","has_exemption":false,"start_date":"2024-10-20","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Universidad Autonoma de Nuevo Leon","sponsor_slug":"universidad-autonoma-de-nuevo-leon","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07285850","publication_url":"https://clinicaltrials.gov/study/NCT07285850","title":"The Efficacy of Sequential Treatment With Bevacizumab Combined With Atezolizumab in Advanced Liver Cancer With MASLD Background: a Dual Arm, Multicenter, Randomized Controlled Study","has_exemption":false,"start_date":"2025-10-20","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Eastern Hepatobiliary Surgery Hospital","sponsor_slug":"eastern-hepatobiliary-surgery-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07217743","publication_url":"https://clinicaltrials.gov/study/NCT07217743","title":"Prospective, Single Center, Open-label Study Assessing Impact of Poly-L-lactic Acid on Adipogenesis in Patients on Glucagon-like Peptide-1 Agonists","has_exemption":false,"start_date":"2025-10-27","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Goldman, Butterwick, Fitzpatrick and Groff","sponsor_slug":"goldman-butterwick-fitzpatrick-and-groff","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07862270","publication_url":"https://clinicaltrials.gov/study/NCT07862270","title":"Comparison of Post-Operative Sensitivity of 5th Genaration Bonding Agent With 8th Generation Bonding Agent in Class1 Composite Restoration","has_exemption":false,"start_date":"2026-03-01","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"Rehman Medical Institute - RMI","sponsor_slug":"rehman-medical-institute-rmi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07432750","publication_url":"https://clinicaltrials.gov/study/NCT07432750","title":"Comparing Efficacy of Osteopathic Manipulation vs. Wrist Immobilization for Carpal Tunnel Syndrome Using Magnetic Resonance Imaging and Patient Perception","has_exemption":false,"start_date":"2026-03-31","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"New York Institute of Technology","sponsor_slug":"new-york-institute-of-technology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07749963","publication_url":"https://clinicaltrials.gov/study/NCT07749963","title":"A Data Collection Study to Collect Blood Pressure (BP) Data Using the CardiacSense BP Watch and CardiacSense Pillow Systems for Algorithm Development","has_exemption":false,"start_date":"2026-07-21","completion_date":"2026-08-30","has_results":false,"results_due":false,"sponsor_name":"CardiacSense Ltd.","sponsor_slug":"cardiacsense-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01798407","publication_url":"https://clinicaltrials.gov/study/NCT01798407","title":"A Clinical Pilot Study Examining Bilateral Inhibition of the Lateral Habenula as a Target for Deep Brain Stimulation in Intractable Depression","has_exemption":false,"start_date":"2013-02-28","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Wayne Goodman MD","sponsor_slug":"wayne-goodman-md","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02844764","publication_url":"https://clinicaltrials.gov/study/NCT02844764","title":"Safety and Effectiveness of Autologous Regenerative Cell Therapy on Pain and Inflammation Associated With Osteoarthritis of the Hip","has_exemption":false,"start_date":"2015-07-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"VivaTech International, Inc.","sponsor_slug":"vivatech-international-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02844751","publication_url":"https://clinicaltrials.gov/study/NCT02844751","title":"Safety and Effectiveness of Autologous Regenerative Cell Therapy on Pain and Inflammation Associated With Osteoarthritis of the Knee","has_exemption":false,"start_date":"2015-07-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"VivaTech International, Inc.","sponsor_slug":"vivatech-international-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02844738","publication_url":"https://clinicaltrials.gov/study/NCT02844738","title":"Safety and Effectiveness of Autologous Regenerative Cell Therapy on Pain and Inflammation Associated With Osteoarthritis of the Shoulder","has_exemption":false,"start_date":"2015-07-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"VivaTech International, Inc.","sponsor_slug":"vivatech-international-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01512888","publication_url":"https://clinicaltrials.gov/study/NCT01512888","title":"A Pilot Feasibility Study of Gene Transfer for X-Linked Severe Combined Immunodeficiency in Newly Diagnosed Infants Using a Self-Inactivating Lentiviral Vector to Transduce Autologous CD34+ Hematopoietic Cells","has_exemption":false,"start_date":"2016-08-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"St. Jude Children's Research Hospital","sponsor_slug":"st-jude-childrens-research-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03347786","publication_url":"https://clinicaltrials.gov/study/NCT03347786","title":"Intraarterial Verapamil for Neuroprotection in Ischemic Stroke","has_exemption":false,"start_date":"2017-04-20","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Global Neurosciences Institute","sponsor_slug":"global-neurosciences-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03257163","publication_url":"https://clinicaltrials.gov/study/NCT03257163","title":"A Phase II Study of Preoperative Pembrolizumab for Mismatch-Repair Deficient and Epstein-Barr Virus Positive Gastric Cancer Followed by Chemotherapy and Chemoradiation With Pembrolizumab","has_exemption":false,"start_date":"2017-09-29","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03618537","publication_url":"https://clinicaltrials.gov/study/NCT03618537","title":"Ixazomib Maintenance Following Initial Therapy in Patients With Immunoglobulin Light Chain (AL) Amyloidosis","has_exemption":false,"start_date":"2018-08-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03619850","publication_url":"https://clinicaltrials.gov/study/NCT03619850","title":"A Phase 3, Randomized, Open-Label, Multicenter Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)","has_exemption":false,"start_date":"2018-08-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AMAG Pharmaceuticals, Inc.","sponsor_slug":"amag-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03539744","publication_url":"https://clinicaltrials.gov/study/NCT03539744","title":"A Phase 3, Multicenter, Randomized, Open Label Study of Venetoclax and Dexamethasone Compared With Pomalidomide and Dexamethasone in Subjects With t(11;14)-Positive Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2018-10-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03575195","publication_url":"https://clinicaltrials.gov/study/NCT03575195","title":"Microbiota Intervention to Change the Response of Parkinson's Disease","has_exemption":false,"start_date":"2019-07-15","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03681275","publication_url":"https://clinicaltrials.gov/study/NCT03681275","title":"A Clinical Trial of JAK Inhibition to Prevent Ventilator-induced Diaphragm Dysfunction","has_exemption":false,"start_date":"2019-09-03","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03991962","publication_url":"https://clinicaltrials.gov/study/NCT03991962","title":"Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2019-09-24","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04045665","publication_url":"https://clinicaltrials.gov/study/NCT04045665","title":"Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG","has_exemption":false,"start_date":"2019-12-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03989206","publication_url":"https://clinicaltrials.gov/study/NCT03989206","title":"A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Moderate-to-Severe Atopic Dermatitis","has_exemption":false,"start_date":"2019-12-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04267003","publication_url":"https://clinicaltrials.gov/study/NCT04267003","title":"Transcranial Direct Current Stimulation (tDCS) Studies of Cognition, Oscillations and GABA Levels in Schizophrenia","has_exemption":false,"start_date":"2020-01-09","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Davis","sponsor_slug":"university-of-california-davis","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04467671","publication_url":"https://clinicaltrials.gov/study/NCT04467671","title":"Prospective, Open-labeled, Single-arm Clinical Trial to Evaluate the Safety and Efficacy of the Second-generation Tissue Engineered Vascular Graft as Vascular Conduits for Extracardiac Total Cavopulmonary Connection.","has_exemption":false,"start_date":"2020-07-15","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Nationwide Children's Hospital","sponsor_slug":"nationwide-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03764098","publication_url":"https://clinicaltrials.gov/study/NCT03764098","title":"Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders","has_exemption":false,"start_date":"2020-08-10","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04503265","publication_url":"https://clinicaltrials.gov/study/NCT04503265","title":"A Phase I/II, Open Label, Multi-center, Non-randomized Dose Escalation and Dose Expansion Study of AMXI-5001 in Patients With Advanced Malignancies","has_exemption":false,"start_date":"2020-08-12","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AtlasMedx, Incorporated","sponsor_slug":"atlasmedx-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04514653","publication_url":"https://clinicaltrials.gov/study/NCT04514653","title":"A Phase 2, Randomized, Dose-escalation, Ranibizumab-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of RGX-314 Gene Therapy Delivered Via One or Two Suprachoroidal Space (SCS) Injections in Participants With Neovascular Age-Related Macular Degeneration (nAMD) (AAVIATE)","has_exemption":false,"start_date":"2020-08-25","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04219280","publication_url":"https://clinicaltrials.gov/study/NCT04219280","title":"Evaluating Assessment and Medication Treatment of ADHD in Children With Down Syndrome","has_exemption":false,"start_date":"2020-10-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04433065","publication_url":"https://clinicaltrials.gov/study/NCT04433065","title":"The Early Feasibility Study of the Transcatheter Tricuspid Valve Replacement System Transfemoral System","has_exemption":false,"start_date":"2020-10-20","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Medtronic Cardiovascular","sponsor_slug":"medtronic-cardiovascular","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04066192","publication_url":"https://clinicaltrials.gov/study/NCT04066192","title":"A Pharmacogenetic Human Laboratory Investigation of Brexpiprazole in Alcohol Use Disorder","has_exemption":false,"start_date":"2020-10-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04807894","publication_url":"https://clinicaltrials.gov/study/NCT04807894","title":"Prevention of Recurrent Urinary Tract Infection Using Vaginal Testosterone Versus Placebo","has_exemption":false,"start_date":"2020-11-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Jefferson Drapkin","sponsor_slug":"jefferson-drapkin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04454528","publication_url":"https://clinicaltrials.gov/study/NCT04454528","title":"Preoperative Use of Radiation Boost to Enhance Effectiveness of Immune Checkpoint Blockade Therapy in Operable Breast Cancer","has_exemption":false,"start_date":"2020-12-07","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Abramson Cancer Center at Penn Medicine","sponsor_slug":"abramson-cancer-center-at-penn-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04388839","publication_url":"https://clinicaltrials.gov/study/NCT04388839","title":"Evolutionary Inspired Therapy for Newly Diagnosed, Metastatic, Fusion Positive Rhabdomyosarcoma","has_exemption":false,"start_date":"2020-12-29","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04467437","publication_url":"https://clinicaltrials.gov/study/NCT04467437","title":"Transcutaneous Spinal Stimulation With Intensive Gait Training for Individuals With Neurologic Conditions","has_exemption":false,"start_date":"2021-01-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04875052","publication_url":"https://clinicaltrials.gov/study/NCT04875052","title":"The Effects of Vibratory Stimuli on Joint Health and Post-traumatic Osteoarthritis Risk Following Anterior Cruciate Ligament Injury","has_exemption":false,"start_date":"2021-01-11","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04786548","publication_url":"https://clinicaltrials.gov/study/NCT04786548","title":"A Precision Medicine Approach to OCD Treatment: Targeting Neuroinflammation","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"New York State Psychiatric Institute","sponsor_slug":"new-york-state-psychiatric-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04833907","publication_url":"https://clinicaltrials.gov/study/NCT04833907","title":"Phase 1/2, Open Label, Sequential Cohort Study of a Single Intracranial Dose of AVASPA Gene Therapy for Treatment of Children With Typical Canavan Disease","has_exemption":false,"start_date":"2021-04-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Myrtelle Inc.","sponsor_slug":"myrtelle-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04704934","publication_url":"https://clinicaltrials.gov/study/NCT04704934","title":"A Phase 3, Multicenter, 2-Arm Randomized, Open-Label Study of Trastuzumab Deruxtecan in Subjects With HER2-Positive Metastatic and/or Unresectable Gastric or Gastro-Esophageal Junction (GEJ) Adenocarcinoma Subjects Who Have Progressed on or After a Trastuzumab-Containing Regimen (DESTINY-Gastric04)","has_exemption":false,"start_date":"2021-05-21","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04573231","publication_url":"https://clinicaltrials.gov/study/NCT04573231","title":"Evaluation of Prostate Specific Membrane Antigen (PSMA) in HER2-negative, Androgen Receptor (AR)-Positive Metastatic Breast Cancer With 18F-DCFPyL PSMA-based PET/CT","has_exemption":false,"start_date":"2021-05-24","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04625127","publication_url":"https://clinicaltrials.gov/study/NCT04625127","title":"GaitBetter: Motor and Cognitive Training for Gait Rehabilitation and Falls Prevention in Stroke Survivors.","has_exemption":false,"start_date":"2021-07-23","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Spaulding Rehabilitation Hospital","sponsor_slug":"spaulding-rehabilitation-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05027477","publication_url":"https://clinicaltrials.gov/study/NCT05027477","title":"Customized Ablation of the Prostate With the TULSA Procedure Against Radical Prostatectomy Treatment: a Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)","has_exemption":false,"start_date":"2021-11-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Profound Medical Inc.","sponsor_slug":"profound-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05163041","publication_url":"https://clinicaltrials.gov/study/NCT05163041","title":"Phase 1/2 Study of the Safety, Pharmacokinetics, and Preliminary Clinical Activity of BT7480 in Patients With Nectin-4 Associated Advanced Malignancies","has_exemption":false,"start_date":"2021-11-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"BicycleTx Limited","sponsor_slug":"bicycletx-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06000592","publication_url":"https://clinicaltrials.gov/study/NCT06000592","title":"Safety, Feasibility, and Efficacy of Transcutaneous Spinal Cord Stimulation on Stabilizing Blood Pressure for Acute Inpatients With Spinal Cord Injury","has_exemption":false,"start_date":"2022-01-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Jill M. Wecht, Ed.D.","sponsor_slug":"jill-m-wecht-edd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05289167","publication_url":"https://clinicaltrials.gov/study/NCT05289167","title":"A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib and Abatacept for the Prevention of Graft-versus-Host-Disease (GvHD) Following Allogenic Hematopoietic Stem Cell Transplantation (HSCT)","has_exemption":false,"start_date":"2022-03-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05264545","publication_url":"https://clinicaltrials.gov/study/NCT05264545","title":"Prospective, Multicenter, Non-randomized, Controlled Clinical Study Utilizing Non-Guided vs. Guided Surgery to Immediately Loaded PrimeTaper Implants in Partially Edentulous Patients","has_exemption":false,"start_date":"2022-03-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"McGuire Institute","sponsor_slug":"mcguire-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05590637","publication_url":"https://clinicaltrials.gov/study/NCT05590637","title":"A Pragmatic Randomized Trial Comparing Antipsychotics in Lewy Body Disease","has_exemption":false,"start_date":"2022-04-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04866472","publication_url":"https://clinicaltrials.gov/study/NCT04866472","title":"Comparison of Video Laryngoscope (VLS) With GlideRite Ridge Stylet vs Video Laryngoscope With the TCI Articulating Indroducer for Endotracheal Intubation in Predicted Difficult Airways. A Prospective Randomized Control Trial","has_exemption":false,"start_date":"2022-04-26","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04863950","publication_url":"https://clinicaltrials.gov/study/NCT04863950","title":"A Phase II, Investigator-Initiated Study of Imipramine Hydrochloride and Lomustine in Recurrent Glioblastoma","has_exemption":false,"start_date":"2022-05-25","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center at San Antonio","sponsor_slug":"the-university-of-texas-health-science-center-at-san-antonio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05251714","publication_url":"https://clinicaltrials.gov/study/NCT05251714","title":"A Dose-confirming Study of CFI-402257 as a Single Agent in Advanced Solid Tumors and in Combination With Fulvestrant in Patients With ER+/HER2- Advanced Breast Cancer After Disease Progression on Prior CDK4/6 and Endocrine Therapy","has_exemption":false,"start_date":"2022-05-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Treadwell Therapeutics, Inc","sponsor_slug":"treadwell-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05211570","publication_url":"https://clinicaltrials.gov/study/NCT05211570","title":"A Phase 1/2 Study to Assess the Safety, Pharmacokinetics, and Efficacy of Daily Intravenous AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia","has_exemption":false,"start_date":"2022-06-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AB Science","sponsor_slug":"ab-science","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05178069","publication_url":"https://clinicaltrials.gov/study/NCT05178069","title":"Lactobacillus Rhamnosus GG: A Novel Probiotic Therapy for Treating Alcohol Use Disorder","has_exemption":false,"start_date":"2022-06-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05580614","publication_url":"https://clinicaltrials.gov/study/NCT05580614","title":"Pairing tVNS and Exposure and Response Prevention to Improve Symptoms of OCD","has_exemption":false,"start_date":"2022-06-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03616236","publication_url":"https://clinicaltrials.gov/study/NCT03616236","title":"Buprenorphine for Probationers and Parolees: Bridging the Gap Into Treatment","has_exemption":false,"start_date":"2022-07-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Friends Research Institute, Inc.","sponsor_slug":"friends-research-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05308264","publication_url":"https://clinicaltrials.gov/study/NCT05308264","title":"An Open-label, Phase 1b Study of R289, an IRAK1/4 Inhibitor, in Patients With Lower-risk Myelodysplastic Syndromes (LR MDS) Who Are Relapsed/Refractory/Resistant to Prior Therapies","has_exemption":false,"start_date":"2022-09-12","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Rigel Pharmaceuticals","sponsor_slug":"rigel-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05490472","publication_url":"https://clinicaltrials.gov/study/NCT05490472","title":"A Phase 1/2a, Multi-Center, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Evidence of Antitumor Activity of JAB-2485 in Adult Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2022-12-20","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Jacobio Pharmaceuticals Co., Ltd.","sponsor_slug":"jacobio-pharmaceuticals-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05480995","publication_url":"https://clinicaltrials.gov/study/NCT05480995","title":"Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone Positron Emission Tomography-Magnetic Resonance Imaging (PET / MRI)","has_exemption":false,"start_date":"2023-01-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05498272","publication_url":"https://clinicaltrials.gov/study/NCT05498272","title":"A Phase 2 Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations (NePtune)","has_exemption":false,"start_date":"2023-02-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Rana McKay, MD","sponsor_slug":"rana-mckay-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05727787","publication_url":"https://clinicaltrials.gov/study/NCT05727787","title":"vGRID SBRT: A Phase I Clinical Trial in Unresectable or Metastatic HCC","has_exemption":false,"start_date":"2023-02-23","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07281521","publication_url":"https://clinicaltrials.gov/study/NCT07281521","title":"Safety & Effectiveness of the CardioWave Pulsed Field Ablation System With the QuickShot Nav Large-Area Focal Catheter for Ablation of Persistent Atrial Fibrillation","has_exemption":false,"start_date":"2023-02-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"CardioFocus","sponsor_slug":"cardiofocus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669482","publication_url":"https://clinicaltrials.gov/study/NCT05669482","title":"A Phase 1b/2a Study of Gemcitabine and Nab-paclitaxel in Combination With Avutometinib (VS-6766) and Defactinib in Patients With Previously Untreated Metastatic Adenocarcinoma of the Pancreas","has_exemption":false,"start_date":"2023-03-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Verastem, Inc.","sponsor_slug":"verastem-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05801861","publication_url":"https://clinicaltrials.gov/study/NCT05801861","title":"Modulating Spatial Processing During Goal-directed Navigation Using Transcranial Magnetic Stimulation","has_exemption":false,"start_date":"2023-03-24","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05869500","publication_url":"https://clinicaltrials.gov/study/NCT05869500","title":"Left Bundle Area Pacing Vs. Right Ventricular Pacing in Patients With Normal Left Ventricular Function -The Boston Pace Study","has_exemption":false,"start_date":"2023-05-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05408546","publication_url":"https://clinicaltrials.gov/study/NCT05408546","title":"Evaluation of the Safety and Thrombolytic Effects of Ascending Doses of TS23 in Subjects With Intermediate-Risk (Sub-Massive) Acute Pulmonary Embolism","has_exemption":false,"start_date":"2023-05-24","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Translational Sciences, Inc.","sponsor_slug":"translational-sciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05495906","publication_url":"https://clinicaltrials.gov/study/NCT05495906","title":"A Study of Reduced Dosing of the Nonavalent HPV Vaccine in Women Living With HIV","has_exemption":false,"start_date":"2023-07-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of British Columbia","sponsor_slug":"university-of-british-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05953961","publication_url":"https://clinicaltrials.gov/study/NCT05953961","title":"Randomized Study of Therapshere 90-Yittrium Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia","has_exemption":false,"start_date":"2023-08-08","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Ochsner Health System","sponsor_slug":"ochsner-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06081894","publication_url":"https://clinicaltrials.gov/study/NCT06081894","title":"A Phase 3, Multi-Center, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy","has_exemption":false,"start_date":"2023-08-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Cytokinetics","sponsor_slug":"cytokinetics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06194838","publication_url":"https://clinicaltrials.gov/study/NCT06194838","title":"Clinical Outcomes Associated With At Home Use of Non-Powered vs. Powered Prosthetic Knees by K2-level Individuals With Transfemoral Amputations","has_exemption":false,"start_date":"2023-09-12","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Liberating Technologies, Inc.","sponsor_slug":"liberating-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05548426","publication_url":"https://clinicaltrials.gov/study/NCT05548426","title":"Pilot Study of Linezolid for Early Syphilis Treatment","has_exemption":false,"start_date":"2023-09-28","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05382403","publication_url":"https://clinicaltrials.gov/study/NCT05382403","title":"Novel Vacuum-Induced Hemorrhage Control for Postpartum Hemorrhage: a Multicenter Randomized Trial","has_exemption":false,"start_date":"2023-10-23","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Women and Infants Hospital of Rhode Island","sponsor_slug":"women-and-infants-hospital-of-rhode-island","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04759274","publication_url":"https://clinicaltrials.gov/study/NCT04759274","title":"Diuretic Tuner Clinical Decision Support Mobile Device Application for Diuretic Titration in Hypervolemic States","has_exemption":false,"start_date":"2023-11-20","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05790252","publication_url":"https://clinicaltrials.gov/study/NCT05790252","title":"Using the Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy: A Randomized Controlled Trial (The Patch BRIDGE Trial)","has_exemption":false,"start_date":"2023-11-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05935358","publication_url":"https://clinicaltrials.gov/study/NCT05935358","title":"Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study (NuPOWER)","has_exemption":false,"start_date":"2023-11-28","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Octapharma","sponsor_slug":"octapharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06088914","publication_url":"https://clinicaltrials.gov/study/NCT06088914","title":"Behavioral and Neural Correlates of Post-Stroke Fatigue","has_exemption":false,"start_date":"2023-12-15","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Texas Woman's University","sponsor_slug":"texas-womans-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05995535","publication_url":"https://clinicaltrials.gov/study/NCT05995535","title":"Pregabalin Plus Lofexidine for the Outpatient Treatment of Opioid Withdrawal","has_exemption":false,"start_date":"2024-01-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06306157","publication_url":"https://clinicaltrials.gov/study/NCT06306157","title":"Low Dose Naltrexone (LDN) Therapy for Complex Regional Pain Syndrome (CRPS): A Feasibility Study","has_exemption":false,"start_date":"2024-01-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05888428","publication_url":"https://clinicaltrials.gov/study/NCT05888428","title":"Regulatory Clearance of a Rehabilitation System for Individuals With Upper Limb Loss","has_exemption":false,"start_date":"2024-02-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Infinite Biomedical Technologies","sponsor_slug":"infinite-biomedical-technologies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04880707","publication_url":"https://clinicaltrials.gov/study/NCT04880707","title":"Myogenous Face Pain Following Third Molar Extractions Under Intravenous Sedation","has_exemption":false,"start_date":"2024-03-11","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07698353","publication_url":"https://clinicaltrials.gov/study/NCT07698353","title":"A Clinical Feasibility Study of the Aquea Intracanalicular Glaucoma Micro-coil Stent","has_exemption":false,"start_date":"2024-04-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Aquea Health, Inc.","sponsor_slug":"aquea-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06336863","publication_url":"https://clinicaltrials.gov/study/NCT06336863","title":"An Extension Protocol for Subjects Previously Enrolled in the \"Use of Donor Derived-cell Free DNA (AlloSure) and Gene Expression Profiling (AlloMap Kidney) to Facilitate Belatacept Monotherapy in Kidney Transplant Patients\"","has_exemption":false,"start_date":"2024-06-14","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06102941","publication_url":"https://clinicaltrials.gov/study/NCT06102941","title":"Cognitive Control Targets for the Treatment of Obsessive Compulsive Disorder in Young Children","has_exemption":false,"start_date":"2024-06-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Columbia University","sponsor_slug":"columbia-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06527365","publication_url":"https://clinicaltrials.gov/study/NCT06527365","title":"An Open-Label Multi-Dose Study to Evaluate the Safety and Efficacy of VDPHL01 in Male and Female Subjects With Androgenetic Alopecia","has_exemption":false,"start_date":"2024-07-08","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Veradermics, Inc.","sponsor_slug":"veradermics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06695884","publication_url":"https://clinicaltrials.gov/study/NCT06695884","title":"Determining the Optimal Pulse Protocol for TMS Induced Change in Reward Positivity","has_exemption":false,"start_date":"2024-08-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Rutgers, The State University of New Jersey","sponsor_slug":"rutgers-the-state-university-of-new-jersey","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07513038","publication_url":"https://clinicaltrials.gov/study/NCT07513038","title":"Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia","has_exemption":false,"start_date":"2024-08-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Boston Children’s Hospital","sponsor_slug":"boston-childrens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06360380","publication_url":"https://clinicaltrials.gov/study/NCT06360380","title":"REFORM-HF™ Reducing Fluid Overload Using Renal Independent systeM in Heart Failure Patients","has_exemption":false,"start_date":"2024-08-12","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AquaPass Medical Ltd.","sponsor_slug":"aquapass-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06041594","publication_url":"https://clinicaltrials.gov/study/NCT06041594","title":"Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)","has_exemption":false,"start_date":"2024-08-19","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Innova Vascular, Inc.","sponsor_slug":"innova-vascular-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06033950","publication_url":"https://clinicaltrials.gov/study/NCT06033950","title":"A Randomized, Double-blind, Placebo-controlled Pragmatic Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure and Reduced Ejection Fraction Who Are Intolerant of or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists (FINALITY-HF)","has_exemption":false,"start_date":"2024-08-20","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Colorado Prevention Center","sponsor_slug":"colorado-prevention-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06556368","publication_url":"https://clinicaltrials.gov/study/NCT06556368","title":"A Prospective, Randomized, Double-masked, Active Comparator-controlled, Multi-center, Three-arm Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal Tarcocimab Tedromer and Tabirafusp Tedromer Compared With Intravitreal Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD)","has_exemption":false,"start_date":"2024-08-23","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Kodiak Sciences Inc","sponsor_slug":"kodiak-sciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05330182","publication_url":"https://clinicaltrials.gov/study/NCT05330182","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled Study of LMN-201 for Prevention of C. Difficile Infection Recurrence","has_exemption":false,"start_date":"2024-08-29","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Lumen Bioscience, Inc.","sponsor_slug":"lumen-bioscience-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06633952","publication_url":"https://clinicaltrials.gov/study/NCT06633952","title":"Accelerating Cognitive Gains From Digital Meditation With Noninvasive Brain Stimulation: A Pilot Study in MCI","has_exemption":false,"start_date":"2024-08-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07678060","publication_url":"https://clinicaltrials.gov/study/NCT07678060","title":"Targeting Fronto-Striatal Neural Circuitry Using Repetitive Transcranial Magnetic Stimulation to Reduce Irritability","has_exemption":false,"start_date":"2024-09-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06633978","publication_url":"https://clinicaltrials.gov/study/NCT06633978","title":"A Pilot Study of the Impact of Personalized Digital Meditation on Improving Sleep and Reducing Stress in MCI","has_exemption":false,"start_date":"2024-09-10","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06553027","publication_url":"https://clinicaltrials.gov/study/NCT06553027","title":"Phase 3, Randomized, Double-Blind, Placebo-Controlled Multicenter Study of CVN424 in Parkinson's Disease Patients With Motor Complications","has_exemption":false,"start_date":"2024-09-20","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Cerevance","sponsor_slug":"cerevance","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04209842","publication_url":"https://clinicaltrials.gov/study/NCT04209842","title":"Utilization of Endoscopically Placed Intra-gastric Balloon in Obese and Morbid Obese Adolescents Combined With Behavioral Support","has_exemption":false,"start_date":"2024-09-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06581575","publication_url":"https://clinicaltrials.gov/study/NCT06581575","title":"A Phase 2, Randomized, Triple-Blinded, Active-Controlled Study to Assess the Safety and Immunogenicity of an Investigational Herpes Zoster (HZ) Vaccine, JCXH-105, in Healthy Subjects ≥ 50 Years of Age","has_exemption":false,"start_date":"2024-10-16","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Immorna Biotherapeutics, Inc.","sponsor_slug":"immorna-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06511778","publication_url":"https://clinicaltrials.gov/study/NCT06511778","title":"sTErnAl heMostasiS Trial (TEAMS Trial)","has_exemption":false,"start_date":"2024-10-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"WakeMed Health and Hospitals","sponsor_slug":"wakemed-health-and-hospitals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06669754","publication_url":"https://clinicaltrials.gov/study/NCT06669754","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Orally Administered Deucrictibant Extended-Release Tablet for Prophylaxis Against Angioedema Attacks in Adolescents and Adults With Hereditary Angioedema","has_exemption":false,"start_date":"2024-12-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Pharvaris Netherlands B.V.","sponsor_slug":"pharvaris-netherlands-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06815354","publication_url":"https://clinicaltrials.gov/study/NCT06815354","title":"Comprehensive Assessment of Cancer Theranostic Response; Investigating the Intent to Change Treatment Decisions Based on TRAQinform Theranostics","has_exemption":false,"start_date":"2024-12-02","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AIQ Solutions","sponsor_slug":"aiq-solutions","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06655610","publication_url":"https://clinicaltrials.gov/study/NCT06655610","title":"External Trigeminal Nerve Stimulation Versus Sham Stimulation for Attention Deficit Hyperactivity Disorder in Children and Adolescents Aged 7-17 Years: Study Protocol for a Pilot and Feasibility Randomized Clinical Trial","has_exemption":false,"start_date":"2024-12-05","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Psychiatric Research Unit, Region Zealand, Denmark","sponsor_slug":"psychiatric-research-unit-region-zealand-denmark","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06384222","publication_url":"https://clinicaltrials.gov/study/NCT06384222","title":"Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) as a Response Monitoring Tool in Patients With High-Risk Prostate Cancer Receiving Neoadjuvant Therapy","has_exemption":false,"start_date":"2024-12-09","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Ivan de Kouchkovsky, MD","sponsor_slug":"ivan-de-kouchkovsky-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06687369","publication_url":"https://clinicaltrials.gov/study/NCT06687369","title":"Randomized, Multicenter, Multinational, Double-Blind Study to Compare the Pharmacokinetics, Efficacy, Safety and Immunogenicity of MB12 (Proposed Pembrolizumab Biosimilar) Versus Keytruda® in Combination With Chemotherapy for the Treatment of Patients With Advanced Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC) (BENITO Study)","has_exemption":false,"start_date":"2024-12-30","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"mAbxience Research S.L.","sponsor_slug":"mabxience-research-sl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06525896","publication_url":"https://clinicaltrials.gov/study/NCT06525896","title":"Research on Effectiveness of Non-surgical Spinal Decompression Therapy and Outcomes With Radiographic Evaluation","has_exemption":false,"start_date":"2025-01-07","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of South Florida","sponsor_slug":"university-of-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06691191","publication_url":"https://clinicaltrials.gov/study/NCT06691191","title":"Switching From Dual Antiplatelet Therapy to Monotherapy With Potent P2Y12 Inhibitors: Pharmadodynamic Comparison Between Prasugrel and Ticagrelor Monotherapy. The Switching Antiplatelet -7 (SWAP-7) Study","has_exemption":false,"start_date":"2025-01-08","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Florida","sponsor_slug":"university-of-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06848946","publication_url":"https://clinicaltrials.gov/study/NCT06848946","title":"Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intracameral Implant) in Conjunction With Cataract Surgery vs. Cataract Surgery Alone","has_exemption":false,"start_date":"2025-01-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Glaukos Corporation","sponsor_slug":"glaukos-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06178289","publication_url":"https://clinicaltrials.gov/study/NCT06178289","title":"The Effectiveness of 3M Cavilon Advanced Skin Protectant in the Treatment of Partial-thickness Wounds Caused by Moisture-associated Skin Damage Compared to Usual Wound Care Treatment in Hospitals: a Multi-centre RCT","has_exemption":false,"start_date":"2025-01-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University Ghent","sponsor_slug":"university-ghent","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06705075","publication_url":"https://clinicaltrials.gov/study/NCT06705075","title":"Evaluation of Uterine Fibroids by Contrast Enhanced Ultrasound (CEUS) and Subharmonic- Aided Pressure Estimation (SHAPE) Pre and Post-Uterine Artery Embolization (UAE)","has_exemption":false,"start_date":"2025-01-27","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06462482","publication_url":"https://clinicaltrials.gov/study/NCT06462482","title":"Peri-Operative Testosterone Administration in Primary Hip Arthroscopy","has_exemption":false,"start_date":"2025-01-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"American Hip Institute","sponsor_slug":"american-hip-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06727110","publication_url":"https://clinicaltrials.gov/study/NCT06727110","title":"Dentin Caries and Polymer-induced Liquid Precursor System (PILP): Adult Safety Study","has_exemption":false,"start_date":"2025-02-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07203326","publication_url":"https://clinicaltrials.gov/study/NCT07203326","title":"Microsurfaced Acellular Dermal Matrix for Root Coverage Procedures","has_exemption":false,"start_date":"2025-02-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06681233","publication_url":"https://clinicaltrials.gov/study/NCT06681233","title":"A Feasibility Study of a Novel Cone-Beam CT Approach for Image Guided Radiotherapy in Cancer Patients","has_exemption":false,"start_date":"2025-02-19","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Varian, a Siemens Healthineers Company","sponsor_slug":"varian-a-siemens-healthineers-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06736392","publication_url":"https://clinicaltrials.gov/study/NCT06736392","title":"Efficacy of Dexmedetomidine As an Adjuvant to Bupivacaine in Ultrasound Guided Pericapsular Nerve Group Block for Postoperative Analgesia During Spinal Anesthesia in Hip Replacement Surgeries, a Randomized Controlled Study","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Assiut University","sponsor_slug":"assiut-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06846515","publication_url":"https://clinicaltrials.gov/study/NCT06846515","title":"A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants With Gout","has_exemption":false,"start_date":"2025-03-11","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Arthrosi Therapeutics","sponsor_slug":"arthrosi-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915818","publication_url":"https://clinicaltrials.gov/study/NCT06915818","title":"GI Windows Flexagon Self Forming Magnet Anastomosis Plus OTOLoc for Creating Ileo-colic and Colo-colonic Anastomoses in Patients Undergoing Surgical Procedures","has_exemption":false,"start_date":"2025-03-29","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"GI Windows, Inc.","sponsor_slug":"gi-windows-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06915337","publication_url":"https://clinicaltrials.gov/study/NCT06915337","title":"GI Windows Flexagon Self Forming Magnet Anastomosis Plus OTOLoc for Creating Gastric-Jejunal Anastomoses in Patients Undergoing Surgical Procedures","has_exemption":false,"start_date":"2025-03-29","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"GI Windows, Inc.","sponsor_slug":"gi-windows-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06984835","publication_url":"https://clinicaltrials.gov/study/NCT06984835","title":"A Prospective, Multi-Center, Randomized, Controlled, Double-Blind, Split-Face Study of the Safety and Effectiveness of ELLANSÉ®-S Dermal Filler in the Treatment of Nasolabial Folds","has_exemption":false,"start_date":"2025-03-31","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"AQTIS Medical B.V.","sponsor_slug":"aqtis-medical-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06906341","publication_url":"https://clinicaltrials.gov/study/NCT06906341","title":"An Open-label, Global, Multi-Arm Study to Evaluate the Efficacy and Safety of Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers (BELLA)","has_exemption":false,"start_date":"2025-04-11","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Corcept Therapeutics","sponsor_slug":"corcept-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06909214","publication_url":"https://clinicaltrials.gov/study/NCT06909214","title":"A Phase 4, Open-Label, Prospective, Single-Group, Multicenter Study to Evaluate the Clinical Outcomes of Efgartigimod PH20 SC in Adult Participants With New-Onset Generalized Myasthenia Gravis","has_exemption":false,"start_date":"2025-04-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"argenx","sponsor_slug":"argenx","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06810804","publication_url":"https://clinicaltrials.gov/study/NCT06810804","title":"A Phase IIa Study to Evaluate the Efficacy and Safety of NBQ72S in Breast Cancer Patients With Leptomeningeal Metastases, With or Without Brain Parenchymal Metastases","has_exemption":false,"start_date":"2025-04-22","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Nantong Bencao Quadriga Medical Technology Co. Ltd.","sponsor_slug":"nantong-bencao-quadriga-medical-technology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07447882","publication_url":"https://clinicaltrials.gov/study/NCT07447882","title":"Unilateral M1 Anodal tDCS to Enhance Learning in a Gross Movement Videogame Task","has_exemption":false,"start_date":"2025-04-23","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06942949","publication_url":"https://clinicaltrials.gov/study/NCT06942949","title":"Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial","has_exemption":false,"start_date":"2025-05-01","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Avvio Medical","sponsor_slug":"avvio-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07029009","publication_url":"https://clinicaltrials.gov/study/NCT07029009","title":"Investigating Enteroendocrine Dysfunction, Metabolism, and Response to Liraglutide in Patients With Maturity-onset Diabetes of the Young (MODY)","has_exemption":false,"start_date":"2025-05-08","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Mansa","sponsor_slug":"mansa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06133387","publication_url":"https://clinicaltrials.gov/study/NCT06133387","title":"PARADIGM Study: Prospective Assessment of a Robotic Assisted Device in Gastrointestinal Medicine - En Bloc Trial With the EndoQuest Endoluminal Surgical (ELS) System","has_exemption":false,"start_date":"2025-05-13","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"EndoQuest Robotics, Inc.","sponsor_slug":"endoquest-robotics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07680244","publication_url":"https://clinicaltrials.gov/study/NCT07680244","title":"(CIRRUS-2023-1) CLINICAL CLIN Assessment of PathFinder 1.0 on the CIRRUS 6000 and the CIRRUS 5000","has_exemption":false,"start_date":"2025-05-23","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Carl Zeiss Meditec-Dublin CoCe","sponsor_slug":"carl-zeiss-meditec-dublin-coce","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07173530","publication_url":"https://clinicaltrials.gov/study/NCT07173530","title":"Low Level Light Therapy & Skin Pigmentation","has_exemption":false,"start_date":"2025-06-11","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Houston","sponsor_slug":"university-of-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06006143","publication_url":"https://clinicaltrials.gov/study/NCT06006143","title":"Feasibility, Acceptability, and Preliminary Efficacy of Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: An Open-Label Pilot Study","has_exemption":false,"start_date":"2025-06-16","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07225829","publication_url":"https://clinicaltrials.gov/study/NCT07225829","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Proof of Concept Trial to Investigate the Efficacy and Safety of Intra-articular 4P004 in Subjects With Knee Synovitis and Osteoarthritis","has_exemption":false,"start_date":"2025-06-17","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"4Moving Biotech","sponsor_slug":"4moving-biotech","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07515664","publication_url":"https://clinicaltrials.gov/study/NCT07515664","title":"Vitamin K Reversal of INR for Perioperative Management of Warfarin: : A Pilot Study to Assess Feasibility","has_exemption":false,"start_date":"2025-07-03","completion_date":"2026-08-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null}]}